Turning Point Brands, Inc. - Quarter Report: 2018 September (Form 10-Q)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
(Mark One)
☑ |
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
For the quarterly period ended September 30, 2018
or
☐ |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
For the transition period from_______________ to ________________
Commission file number: 001-37763
TURNING POINT BRANDS, INC.
(Exact name of registrant as specified in its charter)
Delaware
|
20-0709285
|
|
(State or other jurisdiction of
Incorporation or organization)
|
(I.R.S. Employer
Identification No.)
|
|
5201 Interchange Way, Louisville, KY
|
40229
|
|
(Address of principal executive offices)
|
(Zip Code)
|
(502) 778-4421
(Registrant’s telephone number, including area code)
Former name, former address and former fiscal year, if changed since last report: not applicable
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities
Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☑ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to
Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☑ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting
company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer
|
☐ |
Accelerated filer
|
☑ | |||
Non-accelerated filer
|
☐ (Do not check if a smaller reporting company)
|
Smaller reporting company
|
☐ | |||
Emerging growth company
|
☑ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ☑
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☑
At November 1, 2018, there were 19,549,301 shares outstanding of the registrant’s voting
common stock, par value $0.01 per share.
TURNING POINT BRANDS, INC.
Page No.
|
|||
PART I—FINANCIAL INFORMATION
|
|||
ITEM 1
|
Financial Statements (Unaudited)
|
||
5 |
|||
6 |
|||
7 |
|||
8 |
|||
9 |
|||
10
|
|||
12
|
|||
ITEM 2
|
32
|
||
ITEM 3
|
43
|
||
ITEM 4
|
43
|
||
PART II—OTHER INFORMATION
|
|||
ITEM 1
|
44
|
||
ITEM 1A
|
44
|
||
ITEM 2
|
44
|
||
ITEM 3
|
44
|
||
ITEM 4
|
44
|
||
ITEM 5
|
45
|
||
ITEM 6
|
45
|
||
46
|
Cautionary Note Regarding Forward-Looking Statements
This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of the federal securities laws. Forward-looking statements may
generally be identified by the use of words such as “anticipate,” “believe,” “expect,” “intend,” “plan,” and “will” or, in each case, their negative, or other variations or comparable terminology. These forward-looking statements include all matters
that are not historical facts. By their nature, forward-looking statements involve risks and uncertainties because they relate to events, and depend on circumstances, that may or may not occur in the future. As a result, actual events may differ
materially from those expressed in, or suggested by, the forward-looking statements. Any forward-looking statement made by Turning Point Brands, Inc. (“TPB”), in this Quarterly Report on Form 10-Q speaks only as of the date hereof. New risks and
uncertainties come up from time to time, and it is impossible for TPB to predict these events or how they may affect it. TPB has no obligation, and does not intend, to update any forward-looking statements after the date hereof, except as required by
federal securities laws. Factors that could cause these differences include, but are not limited to:
· |
declining sales of tobacco products, and expected continuing decline of sales, in the tobacco industry overall;
|
· |
our dependence on a small number of third-party suppliers and producers;
|
· |
the possibility that we will be unable to identify or contract with new suppliers or producers in the event of a supply or product
disruption;
|
· |
the possibility that our licenses to use certain brands or trademarks will be terminated, challenged, or restricted;
|
· |
failure to maintain consumer brand recognition and loyalty of our customers;
|
· |
substantial and increasing U.S. regulation;
|
· |
regulation of our products by the Food and Drug Administration (the “FDA”), which has broad regulatory powers;
|
· |
uncertainty related to the regulation and taxation of our NewGen products;
|
· |
possible significant increases in federal, state, and local municipal tobacco-related taxes;
|
· |
possible increasing international control and regulation;
|
· |
our reliance on relationships with several large retailers and national chains for distribution of our products;
|
· |
our amount of indebtedness;
|
· |
the terms of our credit facilities, which may restrict our current and future operations;
|
· |
intense competition and our ability to compete effectively;
|
· |
uncertainty and continued evolution of markets containing our NewGen products;
|
· |
significant product liability litigation;
|
· |
the scientific community’s lack of information regarding the long-term health effects of electronic cigarette, vaporizer, and e-liquid
use;
|
· |
requirement to maintain compliance with Master Settlement Agreement escrow account requirements;
|
· |
competition from illicit sources;
|
· |
our reliance on information technology;
|
· |
security and privacy breaches;
|
· |
contamination of our tobacco supply or products;
|
· |
infringement on our intellectual property;
|
· |
third-party claims that we infringe on their intellectual property;
|
· |
failure to manage our growth;
|
· |
failure to successfully integrate our acquisitions or otherwise be unable to benefit from pursuing acquisitions;
|
· |
fluctuations in our results;
|
· |
exchange rate fluctuations;
|
· |
adverse U.S. and global economic conditions;
|
· |
sensitivity of end-customers to increased sales taxes and economic conditions;
|
· |
failure to comply with certain regulations;
|
· |
departure of key management personnel or our inability to attract and retain talent;
|
· |
imposition of significant tariffs on imports into the U.S.;
|
· |
reduced disclosure requirements applicable to emerging growth companies may make our common stock less attractive to investors,
potentially decreasing our stock price;
|
· |
failure to maintain our status as an emerging growth company before the five-year maximum time period a company may retain such status;
|
· |
our principal stockholders will be able to exert significant influence over matters submitted to our stockholders and may take certain
actions to prevent takeovers;
|
· |
our certificate of incorporation and bylaws, as well as Delaware law and certain regulations, could discourage or prohibit acquisition
bids or merger proposals which may adversely affect the market price of our common stock;
|
· |
our certificate of incorporation limits the ownership of our common stock by individuals and entities that are Restricted Investors.
These restrictions may affect the liquidity of our common stock and may result in Restricted Investors being required to sell or redeem their shares at a loss or relinquish their voting, dividend, and distribution rights;
|
· |
future sales of our common stock in the public market could reduce our stock price, and any additional capital raised by us through the
sale of equity or convertible securities may dilute your ownership in us;
|
· |
we may issue preferred stock whose terms could adversely affect the voting power or value of our common stock; and
|
· |
our status as a “controlled company” could make our common stock less attractive to some investors or otherwise harm our stock price.
|
PART I—FINANCIAL INFORMATION
Turning Point Brands, Inc.
(dollars in thousands except share data)
ASSETS
|
(unaudited)
September 30, |
December 31,
2017 |
||||||
Current assets:
|
||||||||
Cash
|
$
|
1,631
|
$
|
2,607
|
||||
Accounts receivable, net of allowances of $44 in 2018 and $17 in 2017
|
6,603
|
3,248
|
||||||
Inventories
|
89,433
|
63,296
|
||||||
Other current assets
|
14,556
|
10,342
|
||||||
Total current assets
|
112,223
|
79,493
|
||||||
Property, plant, and equipment, net
|
10,585
|
8,859
|
||||||
Deferred income taxes
|
-
|
450
|
||||||
Deferred financing costs, net
|
922
|
630
|
||||||
Goodwill
|
146,328
|
134,620
|
||||||
Other intangible assets, net
|
35,140
|
26,436
|
||||||
Master Settlement Agreement (MSA) escrow deposits
|
29,926
|
30,826
|
||||||
Other assets
|
1,207
|
963
|
||||||
Total assets
|
$
|
336,331
|
$
|
282,277
|
||||
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
||||||||
Current liabilities:
|
||||||||
Accounts payable
|
$
|
8,760
|
$
|
3,686
|
||||
Accrued liabilities
|
17,401
|
18,694
|
||||||
Current portion of long-term debt
|
8,000
|
7,850
|
||||||
Revolving credit facility
|
30,000
|
8,000
|
||||||
Total current liabilities
|
64,161
|
38,230
|
||||||
Notes payable and long-term debt
|
188,529
|
186,190
|
||||||
Deferred income taxes
|
2,178
|
-
|
||||||
Postretirement benefits
|
3,916
|
3,962
|
||||||
Other long-term liabilities
|
558
|
571
|
||||||
Total liabilities
|
259,342
|
228,953
|
||||||
Commitments and contingencies
|
||||||||
Stockholders’ equity:
|
||||||||
Preferred stock; $0.01 par value; authorized shares 40,000,000; issued and outstanding shares -0-
|
-
|
-
|
||||||
Common stock, voting, $0.01 par value; authorized shares, 190,000,000; issued and outstanding shares - 19,540,593 at September 30, 2018, and 19,210,633 at December 31, 2017
|
195
|
192
|
||||||
Common stock, nonvoting, $0.01 par value; authorized shares, 10,000,000; issued and outstanding shares -0-
|
-
|
-
|
||||||
Additional paid-in capital
|
110,074
|
103,640
|
||||||
Accumulated other comprehensive loss
|
(3,681
|
)
|
(2,973
|
)
|
||||
Accumulated deficit
|
(29,599
|
)
|
(47,535
|
)
|
||||
Total stockholders’ equity
|
76,989
|
53,324
|
||||||
Total liabilities and stockholders’ equity
|
$
|
336,331
|
$
|
282,277
|
The accompanying notes are an integral part of the consolidated financial statements.
Turning Point Brands, Inc.
(dollars in thousands except share data)
(unaudited)
Three Months Ended
September 30, |
||||||||
2018
|
2017
|
|||||||
Net sales
|
$
|
83,349
|
$
|
73,340
|
||||
Cost of sales
|
47,138
|
40,372
|
||||||
Gross profit
|
36,211
|
32,968
|
||||||
Selling, general, and administrative expenses
|
23,253
|
18,534
|
||||||
Operating income
|
12,958
|
14,434
|
||||||
Interest expense
|
3,836
|
4,027
|
||||||
Interest income
|
(134
|
)
|
(4
|
)
|
||||
Investment income
|
(89
|
)
|
(131
|
)
|
||||
Net periodic benefit (income) expense, excluding service cost
|
(45
|
)
|
58
|
|||||
Income before income taxes
|
9,390
|
10,484
|
||||||
Income tax expense
|
1,436
|
3,110
|
||||||
Consolidated net income
|
$
|
7,954
|
$
|
7,374
|
||||
Basic income per common share:
|
||||||||
Consolidated net income
|
$
|
0.41
|
$
|
0.39
|
||||
Diluted income per common share:
|
||||||||
Consolidated net income
|
$
|
0.40
|
$
|
0.38
|
||||
Weighted average common shares outstanding:
|
||||||||
Basic
|
19,378,054
|
19,085,329
|
||||||
Diluted
|
19,882,994
|
19,589,424
|
The accompanying notes are an integral part of the consolidated financial statements.
Turning Point Brands, Inc.
(dollars in thousands except share data)
(unaudited)
Nine Months Ended
September 30, |
||||||||
2018
|
2017
|
|||||||
Net sales
|
$
|
238,392
|
$
|
212,214
|
||||
Cost of sales
|
134,577
|
119,508
|
||||||
Gross profit
|
103,815
|
92,706
|
||||||
Selling, general, and administrative expenses
|
66,314
|
53,764
|
||||||
Operating income
|
37,501
|
38,942
|
||||||
Interest expense
|
11,073
|
13,010
|
||||||
Interest income
|
(262
|
)
|
(8
|
)
|
||||
Investment income
|
(328
|
)
|
(334
|
)
|
||||
Loss on extinguishment of debt
|
2,384
|
6,116
|
||||||
Net periodic benefit expense, excluding service cost
|
176
|
174
|
||||||
Income before income taxes
|
24,458
|
19,984
|
||||||
Income tax expense
|
4,153
|
3,850
|
||||||
Consolidated net income
|
20,305
|
16,134
|
||||||
Net loss attributable to non-controlling interest
|
-
|
(556
|
)
|
|||||
Net income attributable to Turning Point Brands, Inc.
|
$
|
20,305
|
$
|
16,690
|
||||
Basic income per common share:
|
||||||||
Net income attributable to Turning Point Brands, Inc.
|
$
|
1.05
|
$
|
0.88
|
||||
Diluted income per common share:
|
||||||||
Net income attributable to Turning Point Brands, Inc.
|
$
|
1.03
|
$
|
0.86
|
||||
Weighted average common shares outstanding:
|
||||||||
Basic
|
19,290,096
|
18,915,606
|
||||||
Diluted
|
19,767,667
|
19,503,130
|
The accompanying notes are an integral part of the consolidated financial statements.
Turning Point Brands, Inc.
(dollars in thousands)
(unaudited)
Three Months Ended
September 30,
|
||||||||
2018
|
2017
|
|||||||
Consolidated net income
|
$
|
7,954
|
$
|
7,374
|
||||
Other comprehensive income (loss), net of tax
|
||||||||
Amortization of unrealized pension and postretirement losses, net of tax of $3 in 2018 and $43 in 2017
|
10
|
71
|
||||||
Unrealized gain (loss) on investments, net of tax of $69 in 2018 and $8 in 2017
|
(231
|
)
|
12
|
|||||
Unrealized loss on interest rate swaps, net of tax of $70 in 2018
|
(233
|
)
|
-
|
|||||
(454
|
)
|
83
|
||||||
Consolidated comprehensive income
|
$
|
7,500
|
$
|
7,457
|
The accompanying notes are an integral part of the consolidated financial statements
Turning Point Brands, Inc.
(dollars in thousands)
(unaudited)
Nine Months Ended
September 30,
|
||||||||
2018
|
2017
|
|||||||
Consolidated net income
|
$
|
20,305
|
$
|
16,134
|
||||
Other comprehensive income (loss), net of tax
|
||||||||
Amortization of unrealized pension and postretirement losses, net of tax of $85 in 2018 and $132 in 2017
|
314
|
218
|
||||||
Unrealized gain (loss) on investments, net of tax of $173 in 2018 and $150 in 2017
|
(738
|
)
|
241
|
|||||
Unrealized loss on interest rate swaps, net of tax of $92 in 2018
|
(308
|
)
|
-
|
|||||
(732
|
)
|
459
|
||||||
Consolidated comprehensive income
|
19,573
|
16,593
|
||||||
Comprehensive loss attributable to non-controlling interest
|
-
|
(556
|
)
|
|||||
Comprehensive income attributable to Turning Point Brands, Inc.
|
$
|
19,573
|
$
|
17,149
|
The accompanying notes are an integral part of the consolidated financial statements
Turning Point Brands, Inc.
(dollars in thousands)
(unaudited)
Nine Months Ended
September 30, |
||||||||
2018
|
2017
|
|||||||
Cash flows from operating activities:
|
||||||||
Consolidated net income
|
$
|
20,305
|
$
|
16,134
|
||||
Adjustments to reconcile net income to net cash provided by operating activities:
|
||||||||
Loss on extinguishment of debt
|
2,384
|
6,116
|
||||||
Loss on sale of property, plant, and equipment
|
-
|
17
|
||||||
Depreciation expense
|
1,596
|
1,192
|
||||||
Amortization of other intangible assets
|
557
|
527
|
||||||
Amortization of deferred financing costs
|
712
|
768
|
||||||
Amortization of original issue discount
|
-
|
66
|
||||||
Deferred income taxes
|
2,806
|
1,847
|
||||||
Stock compensation expense
|
1,056
|
498
|
||||||
Changes in operating assets and liabilities:
|
||||||||
Accounts receivable
|
(3,192
|
)
|
(779
|
)
|
||||
Inventories
|
(18,840
|
)
|
(970
|
)
|
||||
Other current assets
|
(5,971
|
)
|
2,383
|
|||||
Other assets
|
144
|
(105
|
)
|
|||||
Accounts payable
|
4,442
|
(2,292
|
)
|
|||||
Accrued postretirement liabilities
|
(107
|
)
|
(18
|
)
|
||||
Accrued liabilities and other
|
(4,918
|
)
|
(4,993
|
)
|
||||
Net cash provided by operating activities
|
$
|
974
|
$
|
20,391
|
||||
Cash flows from investing activities:
|
||||||||
Capital expenditures
|
$
|
(1,528
|
)
|
$
|
(1,052
|
)
|
||
Restricted cash, MSA escrow deposits
|
(2,234
|
)
|
320
|
|||||
Acquisitions, net of cash acquired
|
(19,161
|
)
|
268
|
|||||
Issuance of note receivable
|
(6,500
|
)
|
-
|
|||||
Receipt of note receivable repayment including prepayment penalty
|
7,475
|
-
|
||||||
Net cash used in investing activities
|
$
|
(21,948
|
)
|
$
|
(464
|
)
|
Turning Point Brands, Inc.
Consolidated Statements of Cash Flows (Cont.)
(dollars in thousands)
(unaudited)
Nine Months Ended
September 30,
|
||||||||
2018
|
2017
|
|||||||
Cash flows from financing activities:
|
||||||||
Proceeds from (payments of) 2018 first lien term loan, net
|
$
|
156,000
|
$
|
-
|
||||
Proceeds from 2018 second lien term loan
|
40,000
|
-
|
||||||
Proceeds from 2018 revolving credit facility
|
30,000
|
-
|
||||||
Payment of dividends
|
(1,537
|
)
|
-
|
|||||
Proceeds from (payments of) 2017 first lien term loans, net
|
(140,613
|
)
|
142,075
|
|||||
Proceeds from (payments of) 2017 second lien term loan, net
|
(55,000
|
)
|
55,000
|
|||||
Proceeds from (payments of) 2017 revolving credit facility, net
|
(8,000
|
)
|
15,550
|
|||||
Payments of VaporBeast Note Payable
|
(2,000
|
)
|
-
|
|||||
Proceeds from release of restricted funds
|
1,107
|
-
|
||||||
Payments of financing costs
|
(3,286
|
)
|
(4,783
|
)
|
||||
Exercise of options
|
779
|
1,371
|
||||||
Payment to terminate acquired capital lease
|
(170
|
)
|
-
|
|||||
Payments of first lien term loan
|
-
|
(147,362
|
)
|
|||||
Payments of second lien term loan
|
-
|
(60,000
|
)
|
|||||
Payments of revolving credit facility
|
-
|
(15,083
|
)
|
|||||
Payments of Vapor Shark loans
|
-
|
(1,867
|
)
|
|||||
Prepaid equity issuance costs
|
-
|
(394
|
)
|
|||||
Surrender of options
|
-
|
(1,000
|
)
|
|||||
Redemption of options
|
(623
|
)
|
(1,740
|
)
|
||||
Distribution to non-controlling interest
|
-
|
(4
|
)
|
|||||
Net cash provided by (used in) financing activities
|
$
|
16,657
|
$
|
(18,237
|
)
|
|||
Net increase (decrease) in cash:
|
$
|
(4,317
|
)
|
$
|
1,690
|
|||
Cash, beginning of period:
|
||||||||
Unrestricted
|
2,607
|
2,865
|
||||||
Restricted
|
4,709
|
3,889
|
||||||
Total cash at beginning of period
|
7,316
|
6,754
|
||||||
Cash, end of period:
|
||||||||
Unrestricted
|
1,631
|
4,235
|
||||||
Restricted
|
1,368
|
4,209
|
||||||
Total cash at end of period
|
$
|
2,999
|
$
|
8,444
|
||||
Supplemental schedule of noncash investing activities:
|
||||||||
Issuance of shares for acquisition
|
$
|
5,292
|
$
|
-
|
The accompanying notes are an integral part of the consolidated financial statements
Turning Point Brands, Inc.
(dollars in thousands, except where designated and per share data)
Note 1. Organizations and Basis of Presentation
Organizations
Turning Point Brands, Inc. (the “Company”), is a holding company which owns North Atlantic Trading Company, Inc. (“NATC”), and its subsidiaries and Turning
Point Brands, LLC (“TPLLC”), and its subsidiaries. Except where the context indicates otherwise, references to the Company include the Company; NATC and its subsidiaries National Tobacco Company, L.P. (“NTC”), National Tobacco Finance, LLC
(“NTFLLC”), North Atlantic Operating Company, Inc. (“NAOC”), North Atlantic Cigarette Company, Inc. (“NACC”), and RBJ Sales, Inc. (“RBJ”); and TPLLC and its subsidiaries Intrepid Brands, LLC (“Intrepid”), Vapor Beast, LLC (“VaporBeast,” f/k/a Smoke
Free Technologies, Inc.), Vapor Shark, LLC, and its subsidiaries (collectively, “Vapor Shark,” f/k/a The Hand Media), Vapor Acquisitions Company, LLC (“Vapor Supply”), Vapor Finance, LLC (“VFIN”), and International Vapor Group, LLC and its
subsidiaries (collectively, “IVG”).
Basis of Presentation
The accompanying interim, condensed, consolidated financial statements have been prepared in accordance with the accounting practices described in the
Company’s audited, consolidated financial statements as of and for the year ended December 31, 2017, and are unaudited. In the opinion of management, the unaudited, interim,
condensed, consolidated financial statements included herein contain all adjustments necessary to present fairly the financial position, results of operations, and cash flows of the Company for the periods indicated. Such adjustments, other than
nonrecurring adjustments separately disclosed, are of a normal and recurring nature. The operating results for interim periods are not necessarily indicative of results to be expected for a full year or future interim periods. The unaudited, interim,
condensed, consolidated financial statements should be read in conjunction with the Company’s audited, consolidated financial statements and accompanying notes as of and for the year ended December 31, 2017. The accompanying interim, condensed,
consolidated financial statements are presented in accordance with the rules and regulations of the Securities and Exchange Commission and, accordingly, do not include all the disclosures required by generally accepted accounting principles in the
United States (“GAAP”) with respect to annual financial statements.
Certain prior year amounts have been reclassified to conform to the current year’s presentation. The changes did not have an impact on the Company’s
consolidated financial position, results of operations, or cash flows in any of the periods presented.
Note 2. Summary of Significant Accounting Policies
Consolidation
The consolidated financial statements include the accounts of the Company and its subsidiaries, all of which are wholly-owned. All significant intercompany
transactions have been eliminated.
Revenue Recognition
The Company adopted Accounting Standards Update (“ASU”) 2014-09, Revenue from Contracts with Customers (Topic 606), which supersedes nearly all existing
revenue recognition guidance under U.S. GAAP, on January 1, 2018. The Company recognizes revenues, net of sales incentives and sales returns, including shipping and handling charges billed to customers, upon delivery of goods to the customer at an
amount that the Company expects to be entitled to in exchange for those goods in accordance with the five-step analysis outlined in Topic 606: (i) identify the contract with the customer, (ii) identify the performance obligations in the contract,
(iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations, and (v) recognize revenue when (or as) performance obligations are satisfied.
A further requirement of ASU 2014-09 is for entities to disaggregate revenue
recognized from contracts with customers into categories that depict how the nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factors. Company management views business performance through segments that
closely resemble the performance of major product lines. Thus, the primary and most useful disaggregation of the Company’s contract revenue for decision making purposes is the disaggregation by segment which can be found in Note 16 of Notes to
Consolidated Financial Statements. An additional disaggregation of contract revenue by sales channel can be found within Note 16 as well.
Shipping Costs
The Company records shipping costs incurred as a component of selling, general, and
administrative expenses. Shipping costs incurred were approximately $3.8 million and $2.9 million for the three months ending September 30, 2018 and 2017, respectively. Shipping
costs incurred were approximately $10.5 million and $7.4 million for the nine months ending September 30, 2018 and 2017, respectively.
Fair Value
GAAP establishes a framework for measuring fair value. That framework provides a fair value hierarchy that prioritizes the inputs to valuation techniques
used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1) and the lowest priority to unobservable inputs (level 3).
The three levels of the fair value hierarchy under GAAP are described below:
· |
Level 1 – Inputs to the valuation methodology are unadjusted quoted prices for identical assets or liabilities in active markets at the measurement date.
|
· |
Level 2 – Inputs to the valuation methodology include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or
liabilities in inactive markets, inputs other than quoted prices that are observable for the asset or liability, and inputs that are derived principally from or corroborated by observable market data by correlation or other means.
|
· |
Level 3 – Unobservable inputs that reflect management’s best estimate of what market participants would use in pricing the asset or liability at the measurement date.
|
Derivative Instruments
Foreign Currency Forward Contracts: The Company enters into foreign
currency forward contracts to hedge a portion of its exposure to changes in foreign currency exchange rates on inventory purchase commitments. The Company accounts for its forward contracts under the provisions of ASC 815, Derivatives and Hedging.
Under the Company’s policy, the Company may hedge up to 100% of its anticipated purchases of inventory in the denominated invoice currency over a forward period not to exceed twelve months. The Company may also, from time to time, hedge up to ninety
percent of its non-inventory purchases in the denominated invoice currency. Forward contracts that qualify as hedges are adjusted to their fair value through other comprehensive income as determined by market prices on the measurement date, except
any hedge ineffectiveness which is recognized currently in income. Gains and losses on these forward contracts are transferred from other comprehensive income into net income as the related inventories are received. Changes in fair value of any
contracts that do not qualify for hedge accounting or are not designated as hedges are recognized currently in income.
Interest Rate Swap Agreements: The Company enters into interest
rate swap contracts to manage interest rate risk and reduce the volatility of future cash flows. The Company accounts for its interest rate swap contracts under the provisions of ASC 815, Derivatives and Hedging. Swap contracts that qualify as hedges
are adjusted to their fair value through other comprehensive income as determined by market prices on the measurement date, except any hedge ineffectiveness which is recognized currently in income. Gains and losses on these swap contracts are
transferred from other comprehensive income into net income upon settlement of the derivative position or at maturity of the interest rate swap contract. Changes in fair value of any contracts that do not qualify for hedge accounting or are not
designated as hedges are recognized currently in income.
Risks and Uncertainties
Manufacturers and sellers of tobacco products are subject to regulation at the federal, state, and local levels. Such regulations include, among others,
labeling requirements, limitations on advertising, and prohibition of sales to minors. The tobacco industry is likely to continue to be heavily regulated. There can be no assurance as to the ultimate content, timing, or effect of any regulation of
tobacco products by any federal, state, or local legislative or regulatory body, nor can there be any assurance that any such legislation or regulation would not have a material adverse effect on the Company’s financial position, results of
operations, or cash flows.
The tobacco industry has experienced, and is experiencing, significant product liability litigation. Most tobacco liability lawsuits have been brought
against manufacturers and sellers of cigarettes for injuries allegedly caused by smoking or exposure to smoke. However, several lawsuits have been brought against manufacturers and sellers of smokeless products for injuries to health allegedly caused
by use of smokeless products. Typically, such claims assert that use of smokeless products is addictive and causes oral cancer. Additionally, several lawsuits have been brought against manufacturers and distributors of NewGen products due to
malfunctioning devices. There can be no assurance the Company will not sustain losses in connection with such lawsuits and that such losses will not have a material adverse effect on the Company’s financial position, results of operations, or cash
flows.
Master Settlement Agreement (MSA): Pursuant to the Master Settlement Agreement (the “MSA”) entered into in November 1998 by most states (represented by their attorneys general acting through the National Association of Attorneys General)
and subsequent states’ statutes, a “cigarette manufacturer” (which is defined to include a manufacturer of make-your-own (“MYO”) cigarette tobacco) has the option of either becoming a signatory to the MSA or opening, funding, and maintaining an
escrow account to have funds available for certain potential tobacco-related liabilities with sub-accounts on behalf of each settling state. The Company chose to open and fund an escrow account as its method of compliance. It is the Company’s policy
to record amounts on deposit in the escrow account for prior years as a non-current asset. Each year’s annual obligation is required to be deposited in the escrow account by April 15 of the following year. In addition to the annual deposit, many
states have elected to require quarterly deposits for the previous quarter’s sales. As of September 30, 2018, the Company had on deposit approximately $32.1 million, the fair value of which was approximately $29.9 million. At December 31, 2017, the
Company had on deposit approximately $32.1 million, the fair value of which was approximately $30.8 million. Effective in the third quarter of 2017, the Company no longer sells any product covered under the MSA. Thus, absent a change in legislation,
the Company will no longer be required to make deposits to the MSA escrow account.
The Company has chosen to invest a portion of the MSA escrow deposits in U.S. Government securities including TIPS, Treasury Notes, and Treasury Bonds. These
investments are classified as available-for-sale and carried at fair value. Realized losses are prohibited under the MSA; any investment in an unrealized loss position will be held until the value is recovered, or until maturity. The following shows
the fair value of the MSA escrow account:
As of September 30, 2018
|
As of December 31, 2017
|
|||||||||||||||||||||||
Cost
|
Gross
Unrealized
Losses |
Estimated
Fair |
Cost
|
Gross
Unrealized
Losses |
Estimated
Fair
Value |
|||||||||||||||||||
Cash and cash equivalents
|
$
|
1,367
|
$
|
-
|
$
|
1,367
|
$
|
3,602
|
$
|
-
|
$
|
3,602
|
||||||||||||
U.S. Governmental agency obligations
|
||||||||||||||||||||||||
(unrealized loss position < 12 months)
|
3,181
|
(53
|
)
|
3,128
|
722
|
(17
|
)
|
705
|
||||||||||||||||
U.S. Governmental agency obligations
|
||||||||||||||||||||||||
(unrealized loss position > 12 months)
|
27,514
|
(2,084
|
)
|
25,430
|
27,733
|
(1,214
|
)
|
26,519
|
||||||||||||||||
$
|
32,062
|
$
|
(2,137
|
)
|
$
|
29,925
|
$
|
32,057
|
$
|
(1,231
|
)
|
$
|
30,826
|
Fair value for the U.S. Governmental agency obligations are Level 2. The following shows the maturities of the U.S. Governmental agency obligations:
As of
|
||||||||
September 30,
2018 |
December 31,
2017 |
|||||||
Less than one year
|
$
|
1,499
|
$
|
-
|
||||
One to five years
|
9,600
|
7,114
|
||||||
Five to ten years
|
15,141
|
17,662
|
||||||
Greater than ten years
|
4,455
|
3,679
|
||||||
Total U.S. Governmental agency obligations
|
$
|
30,695
|
$
|
28,455
|
The following shows the amount of deposits by sales year for the MSA escrow account:
Deposits as of
|
||||||||
Sales
Year
|
September 30,
2018 |
December 31,
2017 |
||||||
1999
|
$
|
211
|
$
|
211
|
||||
2000
|
1,017
|
1,017
|
||||||
2001
|
1,673
|
1,673
|
||||||
2002
|
2,271
|
2,271
|
||||||
2003
|
4,249
|
4,249
|
||||||
2004
|
3,714
|
3,714
|
||||||
2005
|
4,552
|
4,552
|
||||||
2006
|
3,847
|
3,847
|
||||||
2007
|
4,167
|
4,167
|
||||||
2008
|
3,364
|
3,364
|
||||||
2009
|
1,619
|
1,626
|
||||||
2010
|
406
|
406
|
||||||
2011
|
193
|
193
|
||||||
2012
|
199
|
199
|
||||||
2013
|
173
|
173
|
||||||
2014
|
143
|
143
|
||||||
2015
|
101
|
101
|
||||||
2016
|
81
|
81
|
||||||
2017
|
83
|
70
|
||||||
Total
|
$
|
32,063
|
$
|
32,057
|
Food and Drug Administration (“FDA”): On June 22, 2009, the Family
Smoking Prevention and Tobacco Control Act (“FSPTCA”) authorized the FDA to immediately regulate the manufacturing, sale, and marketing of four categories of tobacco products – cigarettes, cigarette tobacco, roll-your-own tobacco, and smokeless
tobacco. On August 8, 2016, the FDA deeming regulation became effective. The deeming regulation gave the FDA the authority to additionally regulate cigars, pipe tobacco, electronic
cigarettes (“e-cigarettes”), vaporizers, and e-liquids as “deemed” tobacco products under the FSPTCA.
The FDA assesses tobacco product user fees on six classes of regulated tobacco products and computes user fees using a methodology similar to the methodology
used by the U.S Department of Agriculture to compute the Tobacco Transition Payment Program (“TTPP,” also known as the “Tobacco Buyout”) assessment. First, the total, annual, congressionally established user fee assessment is allocated among the
various classes of tobacco products using the federal excise tax weighted market share of tobacco products subject to regulation. Then, the assessment for each class of tobacco products is divided among individual manufacturers and importers.
Prior to October 1, 2016, these FDA user fees applied only to those products then regulated by the FDA. Effective October 1, 2016, the FDA began additionally
applying FDA user fees to newly “deemed” tobacco products subject to FDA user fees as described above, i.e., cigars and pipe tobacco.
On July 28, 2017, the FDA announced a new direction in regulating tobacco products, including the newly “deemed” markets such as cigars and vapor products.
The FDA stated it intends to begin several new rulemaking processes, some of which will outline foundational rules governing the premarket application process for the deemed products, including Substantial Equivalence Applications and Premarket
Tobacco Applications. Compliance and related costs could be significant and could increase the costs of operating in our NewGen segment. The original filing deadlines for newly “deemed” products on the market as of August 8, 2016, have been postponed
until August 8, 2021, for “combustible” products (e.g., cigar and pipe) and August 8, 2022, for “non-combustible” products (e.g., vapor products). No other significant filing deadlines have been altered at this time. The FDA also acknowledged a “continuum of risk” among tobacco products (i.e., certain tobacco products pose a greater risk to individual and public health than others), that it intends to seek public comment on the role flavors play in attracting youth
and the role flavors may play in helping some smokers switch to potentially less harmful forms of nicotine delivery, and that it would be increasing its focus on the regulation of cigarette products. FDA has since published a number of Advanced
Notices of Proposed Rulemaking (“ANPRM”) on these subjects.
Recent Accounting Pronouncements Adopted
The Company adopted ASU 2014-09, Revenue from Contracts with Customers
(Topic 606), which supersedes nearly all existing revenue recognition guidance under U.S. GAAP, in the first quarter of 2018 using the modified retrospective method. This ASU requires the recognition of revenue to depict the transfer of
goods to customers at an amount that the Company expects to be entitled to in exchange for those goods in accordance with the following five-step analysis: (i) identify the contract with the customer, (ii) identify the performance obligations in the
contract, (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations, and (v) recognize revenue when (or as) performance obligations are satisfied. Other major provisions include capitalization of
certain contract costs, consideration of time value of money in the transaction price, and allowing estimates of variable consideration to be recognized before contingencies are resolved in certain circumstances. The guidance also requires enhanced
disclosures regarding the nature, amount, timing, and uncertainty of revenue and cash flows arising from an entity’s contracts with customers. The adoption of this ASU had no effect on the timing or amount of revenue recognition, or on net income.
The Company adopted ASU 2018-02, Income Statement—Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income, in the first quarter of 2018 on a prospective basis. This ASU
allows entities to make a one-time reclassification from accumulated other comprehensive income (“AOCI”) to retained earnings for the effects of remeasuring deferred tax liabilities and assets originally recorded in other comprehensive income as a
result of the change in the federal tax rate by the Tax Cuts and Jobs Act (“TCJA”). The adoption of this ASU resulted in a reclassification of stranded tax effects related to the TCJA
from accumulated other comprehensive income to retained earnings of less than $0.1 million during the first quarter of 2018.
The Company adopted ASU 2017-07, Compensation—Retirement Benefits (Topic
715): Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost, in the first quarter of 2018 using the full retrospective method. This ASU requires an entity to report the service cost component in
the same line item or items as other compensation costs arising from services rendered by the pertinent employees during the period. The other components of net periodic benefit cost are required to be presented in the income statement separately
from the service cost component and outside a subtotal of income from operations. The adoption of this ASU resulted in a reclassification of $0.1 million and $0.2 million from cost of sales and selling, general, and administrative expenses to net
periodic benefit (income) expense, excluding service cost, for the three and nine months ended September 30, 2017, respectively.
The Company adopted ASU 2016-18, Statement of Cash Flows (Topic 230):
Restricted Cash, in the first quarter of 2018 using the full retrospective method. The amendments in this ASU require that a statement of cash flows explain the change during the period in the total of cash, cash equivalents, and amounts
generally described as restricted cash or restricted cash equivalents. As a result of this ASU the Company’s statements of cash flows include changes in restricted cash, such as changes in the portion of the MSA escrow deposits held in cash.
Recent Accounting Pronouncements
In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842), which
supersedes Topic 840, Leases. ASU 2016-02 requires a lessee to recognize in the statement of financial position a liability to make lease payments (the lease
liability) and a right-of-use asset representing its right to use the underlying asset (the lease asset) for the lease term. For leases with a term of 12 months or less for which there is not an option to purchase the underlying asset that the lessee
is reasonably certain to exercise, a lessee is permitted to make an accounting policy election by class of underlying asset not to recognize lease assets and lease liabilities and should recognize lease expense for such leases generally on a
straight-line basis over the lease term. Certain qualitative disclosures along with specific quantitative disclosures will be required so that users are able to understand more about the nature of an entity’s leasing activities. ASU 2016-02 is
effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years, with early adoption permitted. At transition, lessees are required to recognize and measure leases at the beginning of the earliest
period presented using a modified retrospective approach, which includes a number of optional practical expedients related to the identification and classification of leases that commenced before the effective date of ASU 2016-02. An entity that
elects to use the practical expedients will, in effect, continue to account for leases that commenced before the effective date in accordance with previous GAAP unless the lease is modified, except that lessees are required to recognize a
right-of-use asset and a lease liability for all operating leases at each reporting date based on the present value of the remaining minimum rental payments that were tracked and disclosed under previous GAAP.
In July 2018, the FASB issued ASU 2018-11, Leases (Topic 842): Targeted
Improvements, providing entities with an additional, optional transition method by which to adopt the new leases standard. ASU 2018-11 allows for application of the new leases standard at adoption date and recognition of a cumulative-effect
adjustment to the opening balance of retained earnings in the period of adoption. The Company will adopt the new leases standard under this optional transition method on January 1, 2019, and does not expect a material adjustment to the opening
balance of retained earnings at adoption. While the Company is still in the process of quantifying the impact to the consolidated balance sheet upon adoption, the Company expects to report increased assets and liabilities as a result of recognizing
right-of-use assets and lease liabilities related to the Company’s operating lease agreements discussed in the Company’s 2017 Annual Report on Form 10-K. However, the Company does not expect adoption of ASU 2016-02 and ASU 2018-11 to have a material
impact on its consolidated statements of income as the majority, if not all, of the Company’s leases are expected to remain operating in nature.
Note 3. Acquisitions
IVG
In September 2018, the Company acquired 100% of the equity interest of IVG
for total consideration of $23.7 million satisfied through $14.4 million paid in cash, 153,079 shares of common stock with a fair value of $5.3 million, and a $4.0 million note payable to IVG’s former owners (“IVG Note”) which matures 18 months
from the acquisition date. All principal and accrued and unpaid interest under the IVG Note is subject to indemnification obligations of the sellers pursuant to the International Vapor Group Stock Purchase Agreement dated as of September
5, 2018. The arrangement includes an additional $4.5 million of earnouts with both performance-based and service-based conditions payable to former IVG owners who became
employees of the Company as a result of the acquisition. The portion of earnout payments a recipient will receive will be calculated by reference to certain performance metrics not to exceed a two-year period as specified within the acquisition
agreement. The Company recorded earnout expense of approximately $0.4 million within the consolidated statement of income for the three months ended September 30, 2018, based on the probability of achieving the performance conditions.
IVG markets and sells a broad array of proprietary and third-party vapor products directly to adult consumers through an online platform under
brand names such as VaporFi, South Beach Smoke, and Direct Vapor. IVG operates company-owned stores under the VaporFi brand and also operates as a franchisor to franchisee-owned stores. The acquisition of IVG adds a significant business-to-consumer
distribution platform to the Company’s NewGen portfolio. As of September 30, 2018, the Company had not completed the accounting for the acquisition. The following purchase price and goodwill are based on the excess of the acquisition price over the
estimated fair value of the tangible and intangible assets acquired and are based on management’s preliminary estimates.
Total purchase price
|
$
|
24,292
|
||
Adjustments to purchase price:
|
||||
Cash acquired
|
(391
|
)
|
||
Working capital
|
(245
|
)
|
||
Adjusted purchase price
|
23,656
|
|||
Assets acquired:
|
||||
Working capital
|
2,681
|
|||
Fixed assets
|
1,296
|
|||
Intangible assets
|
8,140
|
|||
Capital lease obligation
|
(169
|
)
|
||
Net assets acquired
|
11,948
|
|||
Goodwill
|
$
|
11,708
|
The goodwill of $11.7 million consists of the synergies and scale expected from combining the operations and is currently deductible for tax purposes.
Vapor Supply
On April 30, 2018, the Company purchased the assets of Vapor Supply LLC, vaporsupply.com, and some of its affiliates including the Ecig.com domain
through its subsidiary Vapor Acquisitions Company, LLC, for total consideration of $4.8 million paid in cash to strengthen its presence within the NewGen segment. Vapor Supply is a business-to-business e-commerce distribution platform servicing
independent retail vape shops. Additionally, Vapor Supply manufactures and markets proprietary e-liquids under the DripCo brand and operates company-owned stores. As of September 30, 2018, the Company had not completed the accounting for the
acquisition of these assets. The following fair value for working capital (primarily inventory), fixed assets, and trade name are based on management’s preliminary estimates:
Fair Value
|
||||
Working capital
|
$
|
3,181
|
||
Fixed assets
|
498
|
|||
Trade name
|
1,121
|
|||
Total purchase price
|
$
|
4,800
|
Pro Forma Information – IVG and Vapor Supply
The following table presents financial information regarding IVG and Vapor Supply operations included in our Consolidated Statement of Operations from the date of
acquisition through September 30, 2018, under the “Vapor Supply and IVG Actuals from Acquisition Dates through September 30, 2018” column. The following table also presents unaudited pro forma information as if the acquisitions of IVG and Vapor
Supply had occurred on January 1, 2017, under the “Pro Forma Consolidated” columns. The table below has been prepared for comparative purposes only and is not necessarily indicative of the actual results that would have been attained had the
acquisition occurred as of the beginning of the periods presented, nor is it indicative of future results. Furthermore, the unaudited pro forma information does not reflect management’s estimate of any revenue-enhancing opportunities or anticipated
cost savings as a result of the integration and consolidation of the acquisition. Amortization of fair value, interest on debt, and income tax adjustments are included in the numbers below.
Vapor Supply
and IVG Actuals
|
Pro Forma Consolidated
|
|||||||||||
from Acquisition
Dates Through
|
Nine Months Ended
September 30,
|
|||||||||||
September 30, 2018
|
2018
|
2017
|
||||||||||
Net sales
|
$
|
9,737
|
$
|
281,679
|
$
|
270,795
|
||||||
Income (loss) before income taxes
|
(55
|
)
|
24,556
|
21,539
|
||||||||
Net income (loss)
|
$
|
(55
|
)
|
$
|
20,386
|
$
|
17,390
|
|||||
Basic earnings per common share:
|
||||||||||||
Net income
|
$
|
1.06
|
$
|
0.92
|
||||||||
Diluted earnings per common share:
|
||||||||||||
Net income
|
$
|
1.03
|
$
|
0.89
|
||||||||
Weight average common shares outstanding:
|
||||||||||||
Basic - inclusive of voting and non-voting shares
|
19,290,096
|
18,915,606
|
||||||||||
Diluted - inclusive of voting and non-voting shares
|
19,767,667
|
19,503,130
|
Vapor Shark
In March 2017, the Company entered into a strategic partnership with Vapor
Shark in which the Company committed to make a deposit up to $2.5 million to Vapor Shark in exchange for a warrant to purchase 100% of the equity interest in Vapor Shark on or before April 15, 2018. In the event the Company exercised the warrant,
the Company granted Vapor Shark’s sole shareholder the option to purchase from Vapor Shark the retail stores it owns, effective as of January 1, 2018. In April 2017, the Company entered into a management agreement with Vapor Shark whereby the
Company obtained control of the operations. As a result of the management agreement, Vapor Shark was accounted for as a VIE during the second quarter of 2017. The Company exercised its warrant on June 30, 2017, and obtained 100% ownership of Vapor
Shark as of that date for a nominal purchase price. In January 2018, the Company finalized an agreement to pay Vapor Shark’s former sole shareholder total consideration of $1.5 million in exchange for terminating his option to purchase the
company-owned stores. The Company paid Vapor Shark’s former sole shareholder $1.0 million in February 2018 with the remaining $0.5 million to be paid in 24 monthly installments through February 2020.
Note 4. Derivative Instruments
Foreign Currency
The Company’s policy is to manage the risks associated with foreign exchange rate movements. The policy allows hedging up to 100% of its anticipated
purchases of inventory over a forward period that will not exceed 12 rolling and consecutive months. The Company may, from time to time, hedge currency for non-inventory purchases, e.g., production equipment, not to exceed 90% of the purchase price. The Company executed various forward contracts during the three months ended September 30, 2018, none of which met hedge accounting requirements, for
the purchase of €2.3 million. The Company executed various forward contracts during the nine months ended September 30, 2018, none of which met hedge accounting requirements, for the purchase of €14.5 million. The Company executed no forward
contracts during 2017. At September 30, 2018, and December 31, 2017, the Company had forward contracts for the purchase of €5.5 million and €0 million, respectively.
Interest Rate Swaps
The Company’s policy is to manage interest rate risk by reducing the volatility of future cash flows associated with debt instruments bearing interest at
variable rates. In March 2018, the Company executed various interest rate swap agreements for a notional amount of $70 million with an expiration of December 2022. The swap agreements fix LIBOR at 2.755%. The swap agreements met the hedge accounting
requirements; thus, any change in fair value is recorded to other comprehensive income. The Company uses the Shortcut Method to account for the swap agreements. The Shortcut Method assumes the hedge to be perfectly effective; thus, there is no
ineffectiveness to be recorded in earnings. The swap agreements’ fair values at September 30, 2018, resulted in a liability of $0.4 million included in other long-term liabilities.
Note 5. Fair Value of Financial Instruments
The estimated fair value amounts have been determined by the Company using the methods and assumptions described below. However, considerable judgment is
required to interpret market data to develop estimates of fair value. Accordingly, the estimates presented herein are not necessarily indicative of the amounts the Company could realize in a current market exchange. The use of different market
assumptions and/or estimation methodologies may have a material effect on the estimated fair value amounts.
Cash and Cash Equivalents
Cash and cash equivalents are, by definition, short-term. Thus, the carrying amount is a reasonable estimate of fair value.
Accounts Receivable
The fair value of accounts receivable approximates their carrying value due to their short-term nature.
2018 Revolving Credit Facility
The fair value of the 2018 Revolving Credit Facility approximates its carrying value as the interest rate fluctuates with changes in market rates.
Note Payable – IVG
The fair value of the IVG Note approximates its carrying value of $4.0 million due to the recency of the note’s issuance, September 5, 2018,
relative to the end of the quarter, September 30, 2018.
Long-Term Debt
As the Company’s long-term debt bears interest at variable rates that
fluctuate with market rates, the carrying values of the long-term debt instruments approximate their respective fair values. As of September 30, 2018, the fair values of the 2018 First Lien Term Loan and the 2018 Second Lien Term Loan approximated
$156.0 million and $40.0 million, respectively. As of December 31, 2017, the fair values of the 2017 First Lien Term Loans and the 2017 Second Lien Term Loan approximated $140.6 million and $56.1 million, respectively. See Note 10 of Notes
to Consolidated Financial Statements for information regarding our current and past credit facilities.
Foreign Exchange
The Company had forward contracts for the purchase of €5.5 million at September 30, 2018. The Company had no forward contracts outstanding as of December 31, 2017. The fair values of the foreign exchange contracts are based upon quoted
market prices and resulted in a loss of approximately $0.1 million for the nine months ended September 30, 2018. The fair value of the foreign exchange contracts resulted in a liability of less than $0.1 million as of September 30, 2018.
Interest Rate Swaps
The Company had swap contracts for a total notional amount of $70 million at September 30, 2018. The Company had no swap agreements outstanding at
December 31, 2017. The fair values of the swap contracts are based upon quoted market prices and resulted in a liability of $0.4 million as of September 30, 2018.
Note 6. Inventories
The components of inventories are as follows:
September 30,
2018 |
December 31,
2017
|
|||||||
Raw materials and work in process
|
$
|
3,285
|
$
|
2,545
|
||||
Leaf tobacco
|
34,873
|
30,308
|
||||||
Finished goods - Smokeless products
|
7,313
|
5,834
|
||||||
Finished goods - Smoking products
|
13,604
|
14,110
|
||||||
Finished goods - NewGen products
|
35,103
|
14,532
|
||||||
Other
|
722
|
1,290
|
||||||
94,900
|
68,619
|
|||||||
LIFO reserve
|
(5,467
|
)
|
(5,323
|
)
|
||||
$
|
89,433
|
$
|
63,296
|
The inventory valuation allowance was $1.1 million and $0.5 million as of September
30, 2018, and December 31, 2017, respectively.
Note 7. Property, Plant, and Equipment
Property, plant, and equipment consisted of the following:
September 30,
2018 |
December 31,
2017 |
|||||||
Land
|
$
|
22
|
$
|
22
|
||||
Buildings and improvements
|
2,320
|
2,072
|
||||||
Leasehold improvements
|
2,064
|
1,873
|
||||||
Machinery and equipment
|
13,275
|
12,635
|
||||||
Furniture and fixtures
|
4,601
|
3,821
|
||||||
22,282
|
20,423
|
|||||||
Accumulated depreciation
|
(11,697
|
)
|
(11,564
|
)
|
||||
$
|
10,585
|
$
|
8,859
|
Note 8. Other Current Assets
Other current assets consisted of the following:
September 30,
2018 |
December 31,
2017 |
|||||||
Inventory deposits
|
$ |
9,251
|
$ |
3,797
|
||||
Other
|
5,305
|
6,545
|
||||||
$
|
14,556
|
$
|
10,342
|
On May 18, 2018, the Company entered into an arrangement with a supplier which manufactures and distributes vapor products whereby the supplier
received a $6.5 million loan with a maturity date of May 18, 2019. The note was secured by the supplier’s assets and accrued interest at an annual rate of 15% with quarterly interest payments due to the Company which began in August 2018. In
September 2018, the supplier repaid the full outstanding balance of the loan in addition to a $1.0 million early termination fee which was recorded as a reduction to selling, general, and administrative expenses.
Note 9. Accrued Liabilities
Accrued liabilities consisted of the following:
September 30,
2018 |
December 31,
2017 |
|||||||
Accrued payroll and related items
|
$
|
4,142
|
$
|
5,683
|
||||
Customer returns and allowances
|
2,353
|
2,707
|
||||||
Other
|
10,906
|
10,304
|
||||||
$
|
17,401
|
$
|
18,694
|
Note 10. Notes Payable and Long-Term Debt
Notes payable and long-term debt consisted of the following in order of preference:
September 30,
2018 |
December 31,
2017 |
|||||||
2018 First Lien Term Loan
|
$
|
156,000
|
$
|
-
|
||||
2018 Second Lien Term Loan
|
40,000
|
-
|
||||||
Note payable - IVG
|
4,000
|
-
|
||||||
2017 First Lien First Out Term Loan
|
-
|
105,875
|
||||||
2017 First Lien Second Out Term Loan
|
-
|
34,738
|
||||||
2017 Second Lien Term Loan
|
-
|
55,000
|
||||||
Note payable - VaporBeast
|
-
|
2,000
|
||||||
Total notes payable and long-term debt
|
200,000
|
197,613
|
||||||
Less deferred finance charges
|
(3,471
|
)
|
(3,573
|
)
|
||||
Less current maturities
|
(8,000
|
)
|
(7,850
|
)
|
||||
$
|
188,529
|
$
|
186,190
|
2018 Credit Facility
On March 7, 2018, the Company entered into a $250 million credit facility
consisting of a $160 million 2018 First Lien Term Loan with Fifth Third Bank, as administrative agent, and other lenders, and a $50 million 2018 Revolving Credit Facility (collectively, the “2018 First Lien Credit Facility”) in addition to a $40
million 2018 Second Lien Term Loan (together with the 2018 First Lien Credit Facility, the “2018 Credit Facility”) with Prospect Capital Corporation, as administrative agent, and other lenders. The 2018 Credit Facility retained the $40
million accordion feature of the 2017 Credit Facility. Proceeds from the 2018 Credit Facility were used to repay, in full, the 2017 Credit Facility. The Company incurred a loss on extinguishment of debt of $2.4 million in the first quarter of 2018 as
a result of the refinancing.
The 2018 Credit Facility contains customary events of default including payment defaults, breaches of representations and warranties, covenant defaults,
cross-defaults to certain other material indebtedness in excess of specified amounts, certain events of bankruptcy and insolvency, certain ERISA events, judgments in excess of specified amounts, and change in control defaults. The 2018 Credit
Facility also contains certain negative covenants customary for facilities of these types including covenants that, subject to exceptions described in the 2018 Credit Facility, restrict the ability of the Company and its subsidiary guarantors: (i) to
pledge assets, (ii) to incur additional indebtedness, (iii) to pay dividends, (iv) to make distributions, (v) to sell assets, and (vi) to make investments. Refer to Note 17 of Notes to Consolidated Financial Statements for further information
regarding dividend restrictions.
2018 First Lien Credit Facility: The 2018 First
Lien Term Loan and the 2018 Revolving Credit Facility bear interest at LIBOR plus a spread of 2.75% to 3.50% based on the Company’s senior leverage ratio. The 2018 First Lien Term Loan has quarterly required payments of $2.0 million beginning June
30, 2018, increasing to $3.0 million on June 30, 2020, and increasing to $4.0 million on June 30, 2022. The 2018 First Lien Credit Facility has a maturity date of March 7, 2023. The 2018 First Lien Term Loan is secured by a first priority lien on
substantially all of the assets of the borrowers and the guarantors thereunder, including a pledge of the Company’s capital stock, other than certain excluded assets (the “Collateral”). The 2018 First Lien Credit Facility contains certain financial
covenants including maximum senior leverage ratio of 3.50x with step-downs to 3.00x, a maximum total leverage ratio of 4.50x with step-downs to 4.00x, and a minimum fixed charge coverage ratio of 1.20x. The weighted average interest rate of the 2018
First Lien Term Loan was 5.49% at September 30, 2018. The weighted average interest rate of the 2018 Revolving Credit Facility was 6.36% at September 30, 2018. At September 30, 2018, the Company had $30.0 million of borrowings outstanding under the 2018 Revolving Credit Facility. The $20.0
million unused portion of the 2018 Revolving Credit Facility is reduced by a $0.5 million letter of credit with Fifth Third Bank, resulting in $19.5 million of availability under the 2018 Revolving Credit Facility at September 30, 2018.
2018 Second Lien Credit Facility: The 2018
Second Lien Credit Facility bears interest at a rate of LIBOR plus 7.00% and has a maturity date of March 7, 2024. The 2018 Second Lien Term Loan is secured by a second priority interest in the Collateral and is guaranteed by the same entities as the
2018 First Lien Term Loan. The 2018 Second Lien Credit Facility contains certain financial covenants including a maximum senior leverage ratio of 3.75x with step-downs to 3.50x, a maximum total leverage ratio of 4.75x with step-downs to 4.50x, and a
minimum fixed charge coverage ratio of 1.10x. The weighted average interest rate of the 2018 Second Lien Term Loan was 9.15% at September 30, 2018.
Note Payable – IVG
In September 2018, the Company issued a note payable to IVG’s former shareholders (“IVG Note”). The IVG Note is $4.0 million principal with 6.0%
interest compounding annually and matures on March 5, 2020.
2017 Credit Facility
On February 17, 2017, the Company and NATC, entered into a $250 million secured credit facility comprised of (i) a First Lien Credit Facility with
Fifth Third Bank, as administrative agent, and other lenders (the “2017 First Lien Credit Facility”) and (ii) a Second Lien Credit Facility with Prospect Capital Corporation, as administrative agent, and other lenders (the “2017 Second Lien Credit
Facility,” and together with the 2017 First Lien Credit Facility, the “2017 Credit Facility”). The Company used the proceeds of the 2017 Credit Facility to repay, in full, the Company’s prior credit facilities and to pay related fees and expenses. As
a result of this transaction, the Company incurred a loss on extinguishment of debt of $6.1 million during the first quarter of 2017.
Note Payable – VaporBeast
On November 30, 2016, the Company issued a note payable to VaporBeast’s former shareholders (“VaporBeast Note”). The VaporBeast Note was $2.0 million
principal with 6% interest compounded monthly and matured on May 30, 2018, at which time it was paid in full.
Note 11. Income Taxes
In December 2017, the U.S. Congress passed the TCJA which the President signed in the same month. The TCJA reduced the corporate income tax rate to 21%,
effective January 1, 2018. Other significant changes accompanying the corporate income tax rate reduction include eliminating the corporate alternative minimum tax, limiting the interest expense deduction to 30% of adjusted taxable income, and
limiting net operating losses to 80% of taxable income for losses arising in tax years beginning after 2017. The TCJA required the Company to remeasure its deferred tax assets and liabilities at the newly enacted tax rate in December 2017, the period
of enactment.
The Company’s effective income tax rate for the three and nine months ended September 30,
2018, was 15% and 17%, respectively, which includes a tax deduction of $3.3 million and $5.2 million for the three and nine months ended September 30, 2018, relating to stock
option exercises. The Company’s effective income tax rate for the three and nine months ended September 30, 2017, was 30% and 19%, respectively, which includes a tax deduction of
$2.6 million and $11.7 million for the three and nine months ended September 30, 2017, relating to stock option exercises. The Company’s effective income tax rate for the nine
months ended September 30, 2018, also reflected a tax benefit of $0.4 million primarily related to Kentucky corporate income tax changes enacted in April 2018. The significant
impacts to the Company regarding the Kentucky changes included a reduction of the corporate tax rate from 6% to 5% and moving to a single sales factor apportionment formula for tax years beginning on and after January 1, 2018.
The Company follows the provisions of ASC 740-10-25, which prescribes a recognition threshold and measurement attribute for the financial statement
recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The amount
recognized is measured as the largest amount of benefit that is greater than 50 percent likely of being realized upon ultimate settlement. The Company has determined that the Company did not have any uncertain tax positions requiring recognition
under the provisions of ASC 740-10-25. The Company’s policy is to recognize interest and penalties accrued on uncertain tax positions, if any, as part of interest expense. The Company files income tax returns in the U.S. federal jurisdiction and
various state jurisdictions. In general, the Company is no longer subject to U.S. federal and state tax examinations for years prior to 2014.
Note 12. Pension and Postretirement Benefit Plans
The Company has a defined benefit pension plan. Benefits for hourly employees were based on a stated benefit per year of service, reduced by
amounts earned in a previous plan. Benefits for salaried employees were based on years of service and the employees’ final compensation. The defined benefit pension plan is frozen. The Company’s policy is to make the minimum amount of contributions
that can be deducted for federal income taxes. The Company expects to make no contributions to the pension plan in 2018. In the second quarter of 2018, the Company made mutually agreed upon lump-sum payments to certain individuals covered by the
defined benefit pension plan which resulted in a curtailment loss of approximately $0.3 million during the second quarter of 2018.
The Company sponsored a defined benefit postretirement plan that covered hourly employees. This plan provides medical and dental benefits. This plan is
contributory with retiree contributions adjusted annually. The Company’s policy is to make contributions equal to benefits paid during the year. The Company expects to contribute approximately $0.3 million to its postretirement plan in 2018 for the
payment of benefits.
The following table provides the components of net periodic pension and postretirement benefit costs and total costs for the plans:
Three Months Ended September 30,
|
||||||||||||||||
Pension
Benefits
|
Postretirement
Benefits |
|||||||||||||||
2018
|
2017
|
2018
|
2017
|
|||||||||||||
Service cost
|
$
|
26
|
$
|
26
|
$
|
-
|
$
|
-
|
||||||||
Interest cost
|
135
|
164
|
30
|
36
|
||||||||||||
Expected return on plan assets
|
(221
|
)
|
(256
|
)
|
-
|
-
|
||||||||||
Amortization of (gains) losses
|
33
|
114
|
(21
|
)
|
-
|
|||||||||||
Net periodic benefit (income) cost
|
$
|
(27
|
)
|
$
|
48
|
$
|
9
|
$
|
36
|
Nine Months Ended September 30,
|
||||||||||||||||
Pension
Benefits |
Postretirement
Benefits |
|||||||||||||||
2018
|
2017
|
2018
|
2017
|
|||||||||||||
Service cost
|
$
|
78
|
$
|
78
|
$
|
-
|
$
|
-
|
||||||||
Interest cost
|
419
|
484
|
88
|
108
|
||||||||||||
Expected return on plan assets
|
(728
|
)
|
(768
|
)
|
-
|
-
|
||||||||||
Amortization of (gains) losses
|
153
|
350
|
(61
|
)
|
-
|
|||||||||||
Curtailment loss
|
306
|
-
|
-
|
-
|
||||||||||||
Net periodic benefit cost
|
$
|
228
|
$
|
144
|
$
|
27
|
$
|
108
|
Note 13. Share Incentive Plans
On April 28, 2016, the Board of Directors of the Company adopted the Turning Point Brands, Inc., 2015 Equity Incentive Plan (the “2015 Plan”), pursuant to
which awards may be granted to employees, non-employee directors, and consultants. In addition, the 2015 Plan provides for the granting of nonqualified stock options to employees of the Company or any subsidiary of the Company. Pursuant to the 2015
Plan, 1,400,000 shares of the Company’s voting common stock are reserved for issuance as awards to employees, non-employee directors, and consultants as compensation for past or future services or the attainment of certain performance goals. The 2015
Plan is scheduled to terminate on April 27, 2026. The 2015 Plan is administered by a committee (the “Committee”) of the Company’s Board of Directors. The Committee determines the vesting criteria for the awards, with such criteria to be specified in
the award agreement. As of September 30, 2018, net of forfeitures, there were 18,247 shares of restricted stock, 184,000 performance-based restricted stock units, and 297,520 options granted under the 2015 Plan. There are 900,233 shares available for
grant under the 2015 Plan.
On February 8, 2006, the Board of Directors of the Company adopted the 2006 Equity Incentive Plan (the “2006 Plan”) of North Atlantic Holding Company, Inc.,
pursuant to which awards may be granted to employees. The 2006 Plan provides for the granting of nonqualified stock options and restricted stock awards to employees. Upon the adoption of the Company’s 2015 Equity Incentive Plan in connection with its
IPO, the Company determined no additional grants would be made under the 2006 Plan. However, all awards issued under the 2006 Plan that have not been previously terminated or forfeited remain outstanding and continue unaffected.
On February 7, 2017, the Board of Directors of the Company approved stock option cash-out agreements with three Company officers and a director for the
surrender of 83,400 expiring stock options in exchange for payment to the option holders of $11.99 per share. This payment equaled the difference between the exercise price of $1.06 and closing stock price of $13.05 on the approval date, or an
aggregate of $1.0 million.
There are no shares available for grant under the 2006 Plan. Stock option activity for the 2006 and 2015 Plans is summarized below:
Stock
Option |
Weighted
Average |
Weighted
Average |
||||||||||
Outstanding, December 31, 2016
|
1,637,762
|
$
|
2.41
|
$
|
1.23
|
|||||||
Granted
|
133,819
|
14.69
|
4.41
|
|||||||||
Exercised
|
(923,708
|
)
|
1.55
|
0.83
|
||||||||
Forfeited
|
(801
|
)
|
15.37
|
4.59
|
||||||||
Surrendered
|
(83,400
|
)
|
1.06
|
0.54
|
||||||||
Outstanding, December 31, 2017
|
763,672
|
5.73
|
2.36
|
|||||||||
Granted
|
124,100
|
21.27
|
6.33
|
|||||||||
Exercised
|
(196,585
|
)
|
3.96
|
1.42
|
||||||||
Forfeited
|
(13,595
|
)
|
13.08
|
3.71
|
||||||||
Outstanding, September 30, 2018
|
677,592
|
$
|
8.95
|
$
|
3.33
|
Under the 2006 and 2015 Plans, the total intrinsic value of options exercised during the nine months ended September 30, 2018 and 2017, was $5.2 million, and $11.7
million, respectively. The total intrinsic value of options surrendered during the nine months ended September 30, 2017, was $1.0 million.
At September 30, 2018, under the 2006 Plan, the outstanding stock options’ exercise price for 432,227 options is $3.83 per share, all of which are
exercisable. The weighted average of the remaining lives of the outstanding stock options with an exercise price of $3.83 is approximately 4.62 years. The Company estimates the expected life of these stock options is ten years from the date of
grant. For the $3.83 per share options, the weighted average fair value of options was determined using the Black-Scholes model assuming a ten-year life from grant date, a
current share price and exercise price of $3.83, a risk-free interest rate of 3.57%, volatility of 40%, and no assumed dividend yield. Based on these assumptions, the fair value of these options is approximately $2.17 per share option granted.
At September 30, 2018, under the 2015 Plan, the risk-free interest rate is based on the U.S. Treasury rate for the expected life at the time of grant.
The expected volatility is based on the average long-term historical volatilities of peer companies. We intend to continue to consistently use the same group of publicly traded peer companies to determine expected volatility until sufficient
information regarding volatility of our share price becomes available or until the selected companies are no longer suitable for this purpose. Due to our limited trading history, we are using the simplified method presented by SEC Staff
Accounting Bulletin No. 107 to calculate expected holding periods, which represent the periods of time for which options granted are expected to be outstanding. We will continue to use this method until we have sufficient historical exercise
experience to give us confidence in the reliability of our calculations. The fair values of these options were determined using the Black-Scholes option pricing model.
The following table outlines the assumptions based on the number of options granted under the 2015 Plan.
February 10,
2017
|
May 17,
2017
|
March 7,
2018
|
March 13,
2018
|
|||||||||||||
Number of options granted
|
40,000
|
93,819
|
98,100
|
26,000
|
||||||||||||
Options outstanding at September 30, 2018
|
38,300
|
84,665
|
96,400
|
26,000
|
||||||||||||
Number exercisable at September 30, 2018
|
11,900
|
28,572
|
-
|
8,840
|
||||||||||||
Exercise price
|
$
|
13.00
|
$
|
15.41
|
$
|
21.21
|
$
|
21.49
|
||||||||
Remaining lives
|
8.37
|
8.63
|
9.44
|
9.46
|
||||||||||||
Risk free interest rate
|
1.89
|
%
|
1.76
|
%
|
2.65
|
%
|
2.62
|
%
|
||||||||
Expected volatility
|
27.44
|
%
|
26.92
|
%
|
28.76
|
%
|
28.76
|
%
|
||||||||
Expected life
|
6.000
|
6.000
|
6.000
|
5.495
|
||||||||||||
Dividend yield
|
-
|
-
|
0.83
|
%
|
0.82
|
%
|
||||||||||
Fair value at grant date
|
$
|
3.98
|
$
|
4.60
|
$
|
6.37
|
$
|
6.18
|
The Company has recorded compensation expense related to the options based on the provisions of ASC 718 under which the fixed portion of such expense is
determined as the fair value of the options on the date of grant and amortized over the vesting period. The Company recorded compensation expense related to the options of approximately $0.2 million and $0.1 million for the three months ended
September 30, 2018 and 2017. The Company recorded compensation expense related to the options of approximately $0.6 million and $0.2 million for the nine months ended September 30, 2018 and 2017. Total unrecognized compensation expense related to
options at September 30, 2018, is $0.5 million, which will be expensed over 1.93 years.
Performance-Based Restricted Stock Units (“PRSUs”)
PRSUs are restricted stock units subject to both performance-based and service-based vesting conditions. The number of common stock shares a recipient
will receive upon vesting of a PRSU will be calculated by reference to certain performance metrics related to the Company’s performance over a five-year period. PRSUs will vest on the measurement date, which is no more than 65 days after the
performance period (provided the applicable service and performance conditions are satisfied). On March 31, 2017, the Company’s Board of Directors granted 94,000 PRSUs to employees of the Company. On March 7, 2018, the Company’s Board of
Directors granted an additional 96,000 PRSUs to employees of the Company. The fair values of the PRSUs granted on March 31, 2017, and March 7, 2018, are $15.60 and $21.21, respectively, the Company’s stock price on the date of grant. As of
September 30, 2018, there are 184,000 PRSUs outstanding, all of which are unvested. The Company recorded compensation expense related to the PRSUs of approximately $0.2 million and $0.1 million in the consolidated statements of income for the
three months ended September 30, 2018 and 2017, based on the probability of achieving the performance condition. The Company recorded compensation expense related to the PRSUs of approximately $0.4 million and $0.2 million in the consolidated
statements of income for the nine months ended September 30, 2018 and 2017. Total unrecognized compensation expense related to these awards at September 30, 2018, is $2.7 million which will be expensed over the service periods based on the
probability of achieving the performance condition.
Note 14. Contingencies
Other major tobacco companies are defendants in product liability claims. In a number of these cases, the amounts of punitive and compensatory damages
sought are significant and could have a material adverse effect on our business and results of operations. The Company is a defendant in certain cases which have been dormant for many years, which cases have now been dismissed with prejudice.
The Company is subject to several lawsuits alleging personal injuries resulting from malfunctioning vaporizer devices and may be subject to claims in the
future relating to other NewGen products. The Company is still evaluating these claims and the potential defenses to them. For example, the Company did not design or manufacture the products at issue; rather, the Company was merely the
distributor. Nonetheless, there can be no assurance that the Company will prevail in these cases, and they could have a material adverse effect on the financial position, results of operations, or cash flows of the Company.
Note 15. Income Per Share
The following is a reconciliation of the numerators and denominators of the basic and diluted EPS computations of net income:
Three Months Ended September 30,
|
||||||||||||||||||||||||
2018
|
2017
|
|||||||||||||||||||||||
Income
|
Shares
|
Per
Share
|
Income
|
Shares
|
Per
Share
|
|||||||||||||||||||
Consolidated net income
|
$
|
7,954
|
$
|
7,374
|
||||||||||||||||||||
Basic EPS:
|
||||||||||||||||||||||||
Weighted average
|
19,378,054
|
$
|
0.41
|
19,085,329
|
$
|
0.39
|
||||||||||||||||||
Diluted EPS:
|
||||||||||||||||||||||||
Effect of dilutive securities:
|
||||||||||||||||||||||||
Stock options
|
504,940
|
504,095
|
||||||||||||||||||||||
19,882,994
|
$
|
0.40
|
19,589,424
|
$
|
0.38
|
Nine Months Ended September 30,
|
||||||||||||||||||||||||
2018
|
2017
|
|||||||||||||||||||||||
Income
|
Shares
|
Per
Share
|
Income
|
Shares
|
Per
Share
|
|||||||||||||||||||
Net income attributable to Turning Point Brands, Inc.
|
$
|
20,305
|
$
|
16,690
|
||||||||||||||||||||
Basic EPS:
|
||||||||||||||||||||||||
Weighted average
|
19,290,096
|
$
|
1.05
|
18,915,606
|
$
|
0.88
|
||||||||||||||||||
Diluted EPS:
|
||||||||||||||||||||||||
Effect of dilutive securities:
|
||||||||||||||||||||||||
Stock options
|
477,571
|
587,524
|
||||||||||||||||||||||
19,767,667
|
$
|
1.03
|
19,503,130
|
$
|
0.86
|
Note 16. Segment Information
In accordance with ASC 280, Segment Reporting, the Company has three reportable segments: Smokeless products, Smoking products, and NewGen products. The
Smokeless products segment (i) manufactures and markets moist snuff and (ii) contracts for and markets chewing tobacco products. The Smoking products segment (i) markets and distributes cigarette papers, tubes, and related products; (ii) markets
and distributes finished cigars and MYO cigar wraps; and (iii) processes, packages, markets, and distributes traditional pipe tobaccos. The NewGen products segment (i) markets and distributes e-cigarettes, e-liquids, vaporizers, and certain other
products without tobacco and/or nicotine; (ii) distributes a wide assortment of vaping products to non-traditional retail outlets via VaporBeast, Vapor Shark, Vapor Supply, and IVG; and (iii) distributes a wide assortment of vaping related
products to individual consumers via Vapor Shark, Vapor World, and VaporFi branded retail outlets in addition to online platforms. Smokeless and Smoking products are distributed primarily through wholesale distributors in the United States while
NewGen products are distributed primarily through e-commerce to non-traditional retail outlets in the United States. The Other segment includes the costs and assets of the Company not assigned to one of the three reportable segments such as
intercompany transfers, deferred taxes, deferred financing fees, and investments in subsidiaries.
The accounting policies of these segments are the same as those of the Company. Segment data includes a charge allocating corporate costs to the three
reportable segments based on their respective net sales. Prior period corporate costs have been allocated in accordance with the current period allocation methodology to conform prior period segment operating income figures to current period
presentation. The Company evaluates the performance of its segments and allocates resources to them based on gross profit.
The tables below present financial information about reported segments:
Three Months Ended
|
||||||||
September 30,
|
||||||||
2018
|
2017
|
|||||||
Net sales
|
||||||||
Smokeless products
|
$
|
21,743
|
$
|
21,294
|
||||
Smoking products
|
28,079
|
26,860
|
||||||
NewGen products
|
33,527
|
25,186
|
||||||
$
|
83,349
|
$
|
73,340
|
|||||
Gross profit
|
||||||||
Smokeless products
|
$
|
11,020
|
$
|
11,516
|
||||
Smoking products
|
14,814
|
14,201
|
||||||
NewGen products
|
10,377
|
7,251
|
||||||
$
|
36,211
|
$
|
32,968
|
|||||
Operating income (loss)
|
||||||||
Smokeless products (1)
|
$
|
4,114
|
$
|
6,036
|
||||
Smoking products (2)
|
8,595
|
8,958
|
||||||
NewGen products (3)
|
371
|
(535
|
)
|
|||||
Other (4)
|
(122
|
)
|
(25
|
)
|
||||
$
|
12,958
|
$
|
14,434
|
|||||
Interest expense
|
3,836
|
4,027
|
||||||
Interest income
|
(134
|
)
|
(4
|
)
|
||||
Investment income
|
(89
|
)
|
(131
|
)
|
||||
Net periodic benefit (income) expense, excluding service cost
|
(45
|
)
|
58
|
|||||
Income before income taxes
|
$
|
9,390
|
$
|
10,484
|
||||
Capital expenditures
|
||||||||
Smokeless products
|
$
|
251
|
$
|
446
|
||||
Smoking products
|
-
|
-
|
||||||
NewGen products
|
274
|
39
|
||||||
$
|
525
|
$
|
485
|
|||||
Depreciation and amortization
|
||||||||
Smokeless products
|
$
|
342
|
$
|
341
|
||||
Smoking products
|
-
|
-
|
||||||
NewGen products
|
343
|
255
|
||||||
$
|
685
|
$
|
596
|
|||||
(1) Includes allocated corporate charges of $1,748 and $1,734 for the three months ended September 30, 2018 and 2017, respectively.
|
||||||||
(2) Includes allocated corporate charges of $2,266 and $2,187 for the three months ended September 30, 2018 and 2017, respectively.
|
||||||||
(3) Includes allocated corporate charges of $2,168 and $2,061 for the three months ended September 30, 2018 and 2017, respectively.
|
||||||||
(4) “Other” includes the costs that are not assigned to the three reportable segments.
|
Nine Months Ended
|
||||||||
September 30,
|
||||||||
2018
|
2017
|
|||||||
Net sales
|
||||||||
Smokeless products
|
$
|
66,900
|
$
|
63,563
|
||||
Smoking products
|
84,403
|
81,056
|
||||||
NewGen products
|
87,089
|
67,595
|
||||||
$
|
238,392
|
$
|
212,214
|
|||||
Gross profit
|
||||||||
Smokeless products
|
$
|
34,546
|
$
|
32,385
|
||||
Smoking products
|
43,158
|
42,018
|
||||||
NewGen products
|
26,111
|
18,303
|
||||||
$
|
103,815
|
$
|
92,706
|
|||||
Operating income (loss)
|
||||||||
Smokeless products (1)
|
$
|
15,040
|
$
|
15,256
|
||||
Smoking products (2)
|
24,270
|
25,663
|
||||||
NewGen products (3)
|
(1,437
|
)
|
(1,916
|
)
|
||||
Other (4)
|
(372
|
)
|
(61
|
)
|
||||
$
|
37,501
|
$
|
38,942
|
|||||
Interest expense
|
11,073
|
13,010
|
||||||
Interest income
|
(262
|
)
|
(8
|
)
|
||||
Investment income
|
(328
|
)
|
(334
|
)
|
||||
Loss on extinguishment of debt
|
2,384
|
6,116
|
||||||
Net periodic benefit expense, excluding service cost
|
176
|
174
|
||||||
Income before income taxes
|
$
|
24,458
|
$
|
19,984
|
||||
Capital expenditures
|
||||||||
Smokeless products
|
$
|
1,140
|
$
|
973
|
||||
Smoking products
|
-
|
-
|
||||||
NewGen products
|
388
|
79
|
||||||
$
|
1,528
|
$
|
1,052
|
|||||
Depreciation and amortization
|
||||||||
Smokeless products
|
$
|
1,014
|
$
|
1,046
|
||||
Smoking products
|
-
|
-
|
||||||
NewGen products
|
1,139
|
672
|
||||||
$
|
2,153
|
$
|
1,718
|
|||||
(1) Includes allocated corporate charges of $6,010 and $5,324 for the nine months ended September 30, 2018 and 2017, respectively.
|
||||||||
(2) Includes allocated corporate charges of $7,585 and $6,789 for the nine months ended September 30, 2018 and 2017, respectively.
|
||||||||
(3) Includes allocated corporate charges of $6,948 and $5,662 for the nine months ended September 30, 2018 and 2017, respectively.
|
||||||||
(4) “Other” includes the costs that are not assigned to the three reportable segments.
|
September 30,
2018
|
December 31,
2017
|
|||||||
Assets
|
||||||||
Smokeless products
|
$
|
100,199
|
$
|
94,559
|
||||
Smoking products
|
141,129
|
141,869
|
||||||
NewGen products
|
94,020
|
44,914
|
||||||
Other (1)
|
983
|
935
|
||||||
$
|
336,331
|
$
|
282,277
|
(1) “Other” includes the assets that are not assigned to the three reportable segments. All goodwill has been allocated to the
reportable segments.
|
Revenue Disaggregation—Sales Channel
Revenues of the Smokeless and Smoking segments are primarily comprised of sales made to wholesalers while NewGen sales are made to wholesalers,
retailers, and ultimate end-customers. NewGen net sales are broken out by sales channel below.
NewGen Segment
|
||||||||
Three Months Ended
|
||||||||
September 30,
|
||||||||
2018
|
2017
|
|||||||
Wholesalers
|
$
|
1,892
|
$
|
2,818
|
||||
Retail outlets
|
22,473
|
19,889
|
||||||
End-customers
|
9,162
|
2,479
|
||||||
$
|
33,527
|
$
|
25,186
|
NewGen Segment
|
||||||||
Nine Months Ended
|
||||||||
September 30,
|
||||||||
2018
|
2017
|
|||||||
Wholesalers
|
$
|
6,572
|
$
|
7,971
|
||||
Retail outlets
|
63,185
|
53,665
|
||||||
End-customers
|
17,332
|
5,959
|
||||||
$
|
87,089
|
$
|
67,595
|
Net Sales—Domestic vs. Foreign
The following table shows a breakdown of consolidated net sales between domestic and foreign customers.
Three Months Ended
September 30,
|
||||||||
2018
|
2017
|
|||||||
Domestic
|
$
|
78,529
|
$
|
69,484
|
||||
Foreign
|
4,820
|
3,856
|
||||||
Total
|
$
|
83,349
|
$
|
73,340
|
Nine Months Ended
September 30,
|
||||||||
2018
|
2017
|
|||||||
Domestic
|
$
|
226,826
|
$
|
203,210
|
||||
Foreign
|
11,566
|
9,004
|
||||||
Total
|
$
|
238,392
|
$
|
212,214
|
Note 17. Dividends
On November 9, 2017, the Company’s Board of Directors approved the initiation of a cash dividend to shareholders. The initial quarterly dividend of
$0.04 per common share was paid on December 15, 2017, to shareholders of record at the close of business on November 27, 2017. The most recent dividend of $0.04 per common share was paid on October 12, 2018, to shareholders of record at the close
of business on September 24, 2018.
Dividends are classified as restricted payments within the 2018 Credit Facility. The Company is generally permitted to make restricted payments provided that, at the
time of payment, or as a result of payment, the Company is not in default on its debt covenants. Additional restrictions limit the aggregate amount of restricted, quarterly dividends during a fiscal year to the aggregate amount of mandatory and
voluntary principal payments made on the priority term loans during the fiscal year.
You should read the following discussion of the historical financial condition and results of operations in conjunction with our
historical condensed consolidated financial statements and accompanying notes, which are included elsewhere in this Quarterly Report on Form 10-Q. In addition, this discussion includes forward-looking statements subject to risks and uncertainties
that may result in actual results differing from statements we make. See “Cautionary Note Regarding Forward-Looking Statements.” Factors that could cause actual results to differ include those risks and uncertainties discussed in “Risk Factors.”
The following discussion relates to the unaudited financial statements of Turning Point Brands, Inc., included elsewhere in this
Quarterly Report on Form 10-Q. In this discussion, unless the context requires otherwise, references to “our Company” “we,” “our,” or “us” refer to Turning Point Brands, Inc., and its consolidated subsidiaries. References to “TPB” refer to
Turning Point Brands, Inc., without any of its subsidiaries. We were incorporated in 2004 under the name North Atlantic Holding Company, Inc. On November 4, 2015, we changed our name to Turning Point Brands, Inc. Many of the amounts and
percentages in this discussion have been rounded for convenience of presentation.
Organizational Structure
We, Turning Point Brands, Inc., are a holding company which owns North Atlantic Trading Company, Inc. (“NATC”), and its subsidiaries National Tobacco
Company, L.P. (“NTC”), National Tobacco Finance, LLC (“NTFLLC”), North Atlantic Operating Company, Inc. (“NAOC”), North Atlantic Cigarette Company, Inc. (“NACC”), and RBJ Sales, Inc. (“RBJ”), and Turning Point Brands, LLC (“TPLLC”), and its
subsidiaries Intrepid Brands, LLC (“Intrepid”), Vapor Beast, LLC (“VaporBeast”, f/k/a Smoke Free Technologies, Inc.), Vapor Shark, LLC, and its subsidiaries (collectively, “Vapor Shark”, f/k/a The Hand Media), Vapor Acquisitions Company, LLC
(“Vapor Supply”), Vapor Finance, LLC (“VFIN”), and International Vapor Group, LLC and its subsidiaries (collectively, “IVG”).
Overview
We are a leading independent provider of Other Tobacco Products (“OTP”) in the U.S. We
sell a wide range of products across the OTP spectrum including moist snuff tobacco (“MST”), loose leaf chewing tobacco, premium cigarette papers, make-your-own (“MYO”) cigar wraps, cigars, liquid vapor products, and tobacco vaporizer products;
however, we do not sell cigarettes. We estimate the OTP industry generated approximately $11 billion in manufacturer revenue in 2017. In contrast to manufactured cigarettes, which have been experiencing declining volumes for decades based on
data published by the Alcohol and Tobacco Tax and Trade Bureau (“TTB”), the OTP industry is demonstrating increased consumer appeal with low- to mid-single digit
consumer unit growth as reported by Management Science Associates, Inc. (“MSAi”), a third-party analytics and
informatics company. Under the leadership of a senior management team with an average of 22 years of experience in the tobacco industry, we have grown and diversified our business through new product launches, category expansions, and
acquisitions while concurrently improving operational efficiency.
Products
We operate in three segments: Smokeless products, Smoking products and NewGen products. In our Smokeless products segment we (i) manufacture and market
moist snuff and (ii) contract for and market loose leaf chewing tobacco products. In our Smoking products segment, we (i) market and distribute cigarette papers, tubes, and related products; (ii) market and distribute finished cigars and MYO
cigar wraps; and (iii) process, package, market, and distribute traditional pipe tobaccos. In our NewGen products segment, we (i) market and distribute e-cigarettes, e-liquids, vaporizers, and certain other products without tobacco and/or
nicotine; (ii) distribute a wide assortment of vaping related products to non-traditional retail via VaporBeast, Vapor Shark, Vapor Supply, and IVG; and (iii) distribute a wide assortment of vaping related products to individual consumers via
Vapor Shark, Vapor World, and VaporFi branded retail outlets in addition to online platforms. Refer to the ‘Recent Developments’ section below for details regarding the Vapor Supply and IVG acquisitions. Our portfolio of brands includes some of the most widely recognized names in the OTP industry such as Stoker’s® in the Smokeless segment, Zig-Zag® in the Smoking segment, and VaporBeast® in the NewGen segment.
Operations
Our core tobacco business (Smokeless and Smoking segments) primarily generates revenues from the sale of our products to wholesale distributors who, in
turn, resell the products to retail operations. Our acquisition of VaporBeast in the fourth quarter of 2016 expanded our revenue streams as we began selling directly to non-traditional retail outlets and to ultimate consumers via non-traditional
retail outlets as well. Our acquisitions of Vapor Shark in the second quarter of 2017, Vapor Supply in the second quarter of 2018, and IVG in the third quarter of 2018 have further expanded our selling network by allowing us to directly reach
ultimate consumers through Vapor Shark, Vapor World, and VaporFi branded retail outlets. Our net sales, which include federal excise taxes, consist of gross sales net of cash discounts, returns, and selling and marketing allowances.
We rely on long-standing relationships with high-quality, established manufacturers to provide the majority of our produced products. Approximately 85%
of our production, as measured by net sales, is outsourced to suppliers. The remaining 15% represents our moist snuff tobacco operations located in Dresden, TN, and Louisville, KY; the packaging of our pipe tobacco in Louisville, KY; and the
proprietary e-liquids operations located in Oklahoma City, OK, Louisville, KY, and Miami, FL. Our principal operating expenses include the cost of raw materials used to manufacture the limited number of our products which we produce in-house; the
cost of finished products, which are generally purchased goods; federal excise taxes; legal expenses; and compensation expenses, including benefits and costs of salaried personnel. Our other principal expenses include interest expense among other
expenses.
Key Factors Affecting Our Results of Operations
We consider the following to be the key factors affecting our results of operations:
· |
Our ability to further penetrate markets with our existing products;
|
· |
Our ability to introduce new products and product lines that complement our core business;
|
· |
Decreasing interest in some tobacco products among consumers;
|
· |
Price sensitivity in our end-markets;
|
· |
Marketing and promotional initiatives, which cause variability in our results;
|
· |
General economic conditions, including consumer access to disposable income;
|
· |
Cost and increasing regulation of promotional and advertising activities;
|
· |
Cost of complying with regulation, including newly passed “deeming regulations”
|
· |
Counterfeit and other illegal products in our end-markets;
|
· |
Currency fluctuations;
|
· |
Our ability to identify attractive acquisition opportunities in OTP; and
|
· |
Our ability to integrate acquisitions.
|
Recent Developments
VMR
On October 2, 2018, VMR Products LLC (“VMR”), the supplier of V2 e-cigarettes to TPB under a long-term exclusive agreement for retail brick and mortar
distribution and sales, was purchased by Juul Labs for a reported $75 million. Our contract anticipated such an event and affords an acquirer of VMR the right to terminate the contract, subject to certain terms and conditions including product
buyback requirements and a termination payment based on the purchase price. On November 6, 2018, we received a letter from VMR, now owned by Juul Labs, stating that it would no longer accept orders and that we are permitted to continue to
sell-through any V2 inventory. Our net sales of V2 products were $5.5 million for the nine months ended September 30, 2018. We have sufficient inventory on hand to satisfy sales through the first quarter of 2019. Thereafter, we intend to
replace these volumes with new initiatives.
IVG
In September 2018, we acquired IVG for total consideration of $23.7
million satisfied through $14.4 million paid in cash, 153,079 shares of common stock with a fair value of $5.3 million, and a $4.0 million note payable to IVG’s former owners (“IVG Note”) which matures 18 months from the acquisition date. All
principal and accrued and unpaid interest under the IVG Note is subject to indemnification obligations of the sellers pursuant to the International Vapor Group Stock Purchase Agreement dated as of September 5, 2018. The arrangement includes an additional $4.5 million of earnouts with both performance-based and service-based conditions payable to former IVG owners who became employees of
the Company as a result of the acquisition. The portion of earnout payments a recipient will receive will be calculated by reference to certain performance metrics not to exceed a two-year period as specified within the acquisition agreement.
The Company recorded earnout expense of approximately $0.4 million within the consolidated statement of income for the three months ended September 30, 2018, based on the probability of achieving the performance conditions.
IVG markets and sells a broad array of proprietary and third-party vapor products directly to adult consumers through an online platform under
brand names such as VaporFi, South Beach Smoke, and Direct Vapor. IVG operates company-owned stores under the VaporFi brand and also operates as a franchisor to franchisee-owned stores. The acquisition of IVG adds a significant
business-to-consumer distribution platform to the Company’s NewGen portfolio. Refer to Note 3 of Notes to Consolidated Financial Statements for more details regarding the IVG acquisition.
Vapor Supply
On April 30, 2018, we purchased the assets of Vapor Supply LLC, vaporsupply.com, and some of its affiliates including the Ecig.com domain
through our subsidiary Vapor Acquisitions Company, LLC, for total consideration of $4.8 million paid in cash to strengthen its presence within the NewGen segment. Vapor Supply is a business-to-business e-commerce distribution platform servicing
independent retail vape shops. Additionally, Vapor Supply manufactures and markets proprietary e-liquids under the DripCo brand and operates company-owned stores. Refer to Note 3 of Notes to Consolidated Financial Statements for more details
regarding the Vapor Supply acquisition.
Credit Facility Refinancing
On March 7, 2018, we entered into a $250 million credit facility
consisting of a $160 million 2018 First Lien Term Loan with Fifth Third Bank, as administrative agent, and other lenders, and a $50 million 2018 Revolving Credit Facility (collectively, the “2018 First Lien Credit Facility”) in addition to a
$40 million 2018 Second Lien Term Loan (together with the 2018 First Lien Credit Facility, the “2018 Credit Facility”) with Prospect Capital Corporation, as administrative agent, and other lenders. The 2018 Credit Facility retained the
$40 million accordion feature of the 2017 Credit Facility. Proceeds from the 2018 Credit Facility were used to repay, in full, the 2017 Credit Facility. We incurred a loss on extinguishment of debt of $2.4 million in the first quarter of 2018 as
a result of the refinancing. Refer to the Long-Term Debt section for a more complete description of our credit facilities.
Critical Accounting Policies and Uses of Estimates
There have been no material changes to our critical accounting policies and estimates from the information provided in “Management’s Discussion and
Analysis of Financial Condition and Results of Operations” included in our 2017 Annual Report on Form 10-K with the exception of the items listed below.
Revenue Recognition
We adopted Accounting Standards Update (“ASU”) 2014-09, Revenue from Contracts with Customers (Topic 606), which supersedes nearly all existing revenue
recognition guidance under U.S. GAAP, on January 1, 2018. We recognize revenues, net of sales incentives and sales returns, including shipping and handling charges billed to customers, upon delivery of goods to the customer at an amount that we
expect to be entitled to in exchange for those goods in accordance with the five-step analysis outlined in Topic 606: (i) identify the contract with the customer, (ii) identify the performance obligations in the contract, (iii) determine the
transaction price, (iv) allocate the transaction price to the performance obligations, and (v) recognize revenue when (or as) performance obligations are satisfied.
A further requirement of ASU 2014-09 is for entities to disaggregate revenue
recognized from contracts with customers into categories that depict how the nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factors. Our management views business performance through segments that
closely resemble the performance of major product lines. Thus, the primary, and most useful, disaggregation of our contract revenue for decision making purposes is the disaggregation by segment which can be found in Note 16 of Notes to
Consolidated Financial Statements. An additional disaggregation of contract revenue by sales channel can be found within Note 16 as well.
Interest Rate Swaps
We enter into interest rate swap contracts to manage interest rate risk and reduce the volatility of future cash flows. We account for
interest rate swap contracts under the provisions of ASC 815, Derivatives and Hedging. Swap contracts that qualify as hedges are adjusted to their fair value through other comprehensive income as determined by market prices on the measurement
date, except any hedge ineffectiveness which is recognized currently in income. Gains and losses on these swap contracts are transferred from other comprehensive income into net income upon settlement of the derivative position or at maturity
of the interest rate swap contract. Changes in fair value of any contracts that do not qualify for hedge accounting or are not designated as hedges are recognized currently in income.
Recent Accounting Pronouncements
Refer to Note 2 of Notes to Consolidated Financial Statements included in this Quarterly Report for a description of recently issued accounting
pronouncements, including those recently adopted.
Results of Operations
Comparison of the Three Months Ended September 30, 2018, to the Three Months Ended September 30, 2017
The table and discussion set forth below displays our consolidated results of operations (in thousands):
Three Months Ended September 30,
|
||||||||||||
2018
|
2017
|
% Change
|
||||||||||
Consolidated Results of Operations Data:
|
||||||||||||
Net sales
|
||||||||||||
Smokeless products
|
$
|
21,743
|
$
|
21,294
|
2.1
|
%
|
||||||
Smoking products
|
28,079
|
26,860
|
4.5
|
%
|
||||||||
NewGen products
|
33,527
|
25,186
|
33.1
|
%
|
||||||||
Total net sales
|
83,349
|
73,340
|
13.6
|
%
|
||||||||
Cost of sales
|
47,138
|
40,372
|
16.8
|
%
|
||||||||
Gross profit
|
||||||||||||
Smokeless products
|
11,020
|
11,516
|
-4.3
|
%
|
||||||||
Smoking products
|
14,814
|
14,201
|
4.3
|
%
|
||||||||
NewGen products
|
10,377
|
7,251
|
43.1
|
%
|
||||||||
Total gross profit
|
36,211
|
32,968
|
9.8
|
%
|
||||||||
Selling, general, and administrative expenses
|
23,253
|
18,534
|
25.5
|
%
|
||||||||
Operating income
|
12,958
|
14,434
|
-10.2
|
%
|
||||||||
Interest expense
|
3,836
|
4,027
|
-4.7
|
%
|
||||||||
Interest income
|
(134
|
)
|
(4
|
)
|
NM
|
|||||||
Investment income
|
(89
|
)
|
(131
|
)
|
-32.1
|
%
|
||||||
Net periodic benefit (income) expense, excluding service cost
|
(45
|
)
|
58
|
NM
|
||||||||
Income before income taxes
|
9,390
|
10,484
|
-10.4
|
%
|
||||||||
Income tax expense
|
1,436
|
3,110
|
-53.8
|
%
|
||||||||
Consolidated net income
|
$ |
7,954
|
$ |
7,374
|
7.9
|
%
|
Net Sales: For the three months ended
September 30, 2018, consolidated net sales increased to $83.3 million from $73.3 million for the three months ended September 30, 2017, an increase of $10.0 million or 13.6%. The increase in net sales was primarily driven by volume growth in
Smoking and NewGen which includes the addition of one month of IVG sales in 2018.
For the three months ended September 30, 2018, net sales in the Smokeless products segment increased to $21.7 million from $21.3 million for
the three months ended September 30, 2017, an increase of $0.4 million or 2.1%. For the three months ended September 30, 2018, volume decreased 2.2% and price/mix increased 4.3%. The increase in net sales was primarily driven by the continuing
growth of Stoker’s® MST
partially offset by declines in chewing tobacco attributable to increased competition, our promotional timing, and a continuing segment shift to lower price products.
For the three months ended September 30, 2018, net sales in the Smoking products segment increased to $28.1 million from $26.9 million for the
three months ended September 30, 2017, an increase of $1.2 million or 4.5%. For the three months ended September 30, 2018, volume increased 3.0% and price/mix increased 1.5%. Net sales growth was primarily driven by volume growth for our Zig-Zag® branded papers and cigar wraps equating to $2.0 million of increases offset by $0.7 million of decreases related to our strategic decision to de-emphasize the low margin cigar products business and line rationalization of our MYO tobacco line.
For the three months ended September 30, 2018, net sales in the NewGen products segment increased to $33.5 million from $25.2 million for the
three months ended September 30, 2017, an increase of $8.3 million or 33.1%. The increase in net sales was primarily driven by continued VaporBeast momentum, Vapor Supply net sales, and one month of IVG net sales.
Gross Profit: For the three months ended
September 30, 2018, consolidated gross profit increased to $36.2 million from $33.0 million for the three months ended September 30, 2017, an increase of $3.2 million or 9.8%. Gross profit as a percentage of revenue decreased to 43.4% for the
three months ended September 30, 2018, from 45.0% for the three months ended September 30, 2017, primarily due to the NewGen segment, which has lower margins, becoming a larger share of the Company.
For the three months ended September 30, 2018, gross profit in the Smokeless products segment decreased to $11.0 million from $11.5 million for
the three months ended September 30, 2017, a decrease of $0.5 million or 4.3%. Gross profit as a percentage of net sales decreased to 50.7% of net sales for the three months ended September 30, 2018, from 54.1% of net sales for the three months
ended September 30, 2017. The decrease in gross profit as a percentage of revenue was primarily driven by an unfavorable LIFO impact when compared to the prior year.
For the three months ended September 30, 2018, gross profit in the Smoking products segment increased to $14.8 million from $14.2 million for
the three months ended September 30, 2017, an increase of $0.6 million or 4.3%. Gross profit as a percentage of net sales decreased to 52.8% of net sales for the three months ended September 30, 2018, from 52.9% of net sales for the three months
ended September 30, 2017, primarily due to an unfavorable LIFO impact when compared to the prior year.
For the three months ended September 30, 2018, gross profit in the NewGen products segment increased to $10.4 million from $7.3 million for the
three months ended September 30, 2017, an increase of $3.1 million or 43.1%. Gross profit as a percentage of net sales increased to 31.0% of net sales for the three months ended September 30, 2018, from 28.8% of net sales for the three months
ended September 30, 2017, primarily as a result of the addition of IVG, a business-to-consumer operation which generally has higher margins, in 2018.
Selling, General, and Administrative Expenses:
For the three months ended September 30, 2018, selling, general, and administrative expenses increased to $23.3 million from $18.5 million for the three months ended September 30, 2017, an increase of $4.7 million or 25.5% due primarily to the
inclusion of Vapor Supply and IVG selling, general, and administrative expenses, transaction costs associated with the IVG acquisition and variable costs associated with increased sales at VaporBeast partially offset by the prepayment penalty
associated with the loan made to a supplier during the second quarter of 2018.
Interest Expense: For the three months
ended September 30, 2018, interest expense decreased to $3.8 million from $4.0 million for the three months ended September 30, 2017, as a result of lower interest rates from our March 2018 refinancing of our credit facility.
Interest Income: For the three months
ended September 30, 2018, interest income increased to $0.1 million from less than $0.1 million for the three months ended September 30, 2017, as a result of interest received from a note receivable issued to a supplier during the second quarter
of 2018.
Income Tax Expense: Our income tax expense
of $1.4 million was 15.3% of income before income taxes for the three months ended September 30, 2018 compared to 29.7% for the three months ended September 30, 2017. The decrease is primarily a result of the change in the federal tax rate from
35% to 21% and the change in the Kentucky tax rate from 6% to 5%.
Investment Income: Investment income
relating to investment of the MSA escrow deposits was approximately $0.1 million for the three months ended September 30, 2018 and 2017.
Consolidated Net Income: Due to the factors
described above, consolidated net income for the three months ended September 30, 2018 and 2017, was $8.0 million and $7.4 million, respectively.
Comparison of the Nine Months Ended September 30, 2018, to the Nine Months Ended September 30, 2017
The table and discussion set forth below displays our consolidated results of operations (in thousands):
Nine Months Ended September 30,
|
||||||||||||
2018
|
2017
|
% Change
|
||||||||||
Consolidated Results of Operations Data:
|
||||||||||||
Net sales
|
||||||||||||
Smokeless products
|
$
|
66,900
|
$
|
63,563
|
5.2
|
%
|
||||||
Smoking products
|
84,403
|
81,056
|
4.1
|
%
|
||||||||
NewGen products
|
87,089
|
67,595
|
28.8
|
%
|
||||||||
Total net sales
|
238,392
|
212,214
|
12.3
|
%
|
||||||||
Cost of sales
|
134,577
|
119,508
|
12.6
|
%
|
||||||||
Gross profit
|
||||||||||||
Smokeless products
|
34,546
|
32,385
|
6.7
|
%
|
||||||||
Smoking products
|
43,158
|
42,018
|
2.7
|
%
|
||||||||
NewGen products
|
26,111
|
18,303
|
42.7
|
%
|
||||||||
Total gross profit
|
103,815
|
92,706
|
12.0
|
%
|
||||||||
Selling, general, and administrative expenses
|
66,314
|
53,764
|
23.3
|
%
|
||||||||
Operating income
|
37,501
|
38,942
|
-3.7
|
%
|
||||||||
Interest expense
|
11,073
|
13,010
|
-14.9
|
%
|
||||||||
Interest income
|
(262
|
)
|
(8
|
)
|
NM
|
|||||||
Investment income
|
(328
|
)
|
(334
|
)
|
-1.8
|
%
|
||||||
Loss on extinguishment of debt
|
2,384
|
6,116
|
-61.0
|
%
|
||||||||
Net periodic benefit expense, excluding service cost
|
176
|
174
|
1.1
|
%
|
||||||||
Income before income taxes
|
24,458
|
19,984
|
22.4
|
%
|
||||||||
Income tax expense
|
4,153
|
3,850
|
7.9
|
%
|
||||||||
Consolidated net income
|
20,305
|
16,134
|
25.9
|
%
|
||||||||
Net loss attributable to non-controlling interest
|
-
|
(556
|
)
|
NM
|
||||||||
Net income attributable to Turning Point Brands, Inc.
|
$
|
20,305
|
$
|
16,690
|
21.7
|
%
|
Net Sales: For the nine months ended
September 30, 2018, consolidated net sales increased to $238.4 million from $212.2 million for the nine months ended September 30, 2017, an increase of $26.2 million or 12.3%. The increase in net sales was primarily driven by volume growth in the
NewGen segment which includes an additional quarter of Vapor Shark results in 2018 and the acquisitions of Vapor Supply and IVG.
For the nine months ended September 30, 2018, net sales in the Smokeless products segment increased to $66.9 million from $63.6 million for the
nine months ended September 30, 2017, an increase of $3.3 million or 5.2% primarily due to the continuing growth of Stoker’s® MST.
For the nine months ended September 30, 2018, net sales in the Smoking products segment increased to $84.4 million from $81.1 million for the
nine months ended September 30, 2017, an increase of $3.3 million or 4.1% primarily driven by the continued growth of our Zig-Zag® branded papers and cigar wraps
offset by decreases related to our strategic decision to de-emphasize the low margin cigar products business and line rationalization of our MYO tobacco line.
For the nine months ended September 30, 2018, net sales in the NewGen products segment increased to $87.1 million from $67.6 million for the
nine months ended September 30, 2017, an increase of $19.5 million or 28.8%. The increase in net sales was primarily driven by continued VaporBeast momentum, one additional quarter of Vapor Shark results in 2018, and the acquisitions of Vapor
Supply and IVG.
Gross Profit: For the nine months ended
September 30, 2018, consolidated gross profit increased to $103.8 million from $92.7 million for the nine months ended September 30, 2017, an increase of $11.1 million or 12.0%. Gross profit as a percentage of revenue decreased to 43.5% for the
nine months ended September 30, 2018, from 43.7% for the nine months ended September 30, 2017, primarily due to the NewGen segment, which has lower margins, becoming a larger share of the Company.
For the nine months ended September 30, 2018, gross profit in the Smokeless products segment increased to $34.5 million from $32.4 million
for the nine months ended September 30, 2017, an increase of $2.2 million or 6.7%. Gross profit as a percentage of net sales increased to 51.6% of net sales for the nine months ended September 30, 2018, from 50.9% of net sales for the nine
months ended September 30, 2017. The increase in gross profit as a percentage of revenue is primarily due to a favorable LIFO impact when compared to the prior year.
For the nine months ended September 30, 2018, gross profit in the Smoking products segment increased to $43.2 million from $42.0 million for
the nine months ended September 30, 2017, an increase of $1.1 million or 2.7%. Gross profit as a percentage of net sales decreased to 51.1% of net sales for the nine months ended September 30, 2018, from 51.8% of net sales for the nine months
ended September 30, 2017, primarily due to new product launch costs associated with our Zig-Zag® branded papers and cigar wraps product lines.
For the nine months ended September 30, 2018, gross profit in the NewGen products segment increased to $26.1 million from $18.3 million for the
nine months ended September 30, 2017, an increase of $7.8 million or 42.7%. Gross profit as a percentage of net sales increased to 30.0% of net sales for the nine months ended September 30, 2018, from 27.1% of net sales for the nine months ended
September 30, 2017, primarily due to acquisition activity which has resulted in business-to-consumer sales, which generally have higher margins, becoming a larger share of the NewGen segment.
Selling, General, and Administrative Expenses:
For the nine months ended September 30, 2018, selling, general, and administrative expenses increased to $66.3 million from $53.8 million for the nine months ended September 30, 2017, an increase of $12.6 million or 23.3%, due primarily to the
inclusion of Vapor Supply and IVG selling, general, and administrative expenses in 2018 along with an additional quarter of Vapor Shark when compared to 2017, transaction costs associated with the Vapor Supply and IVG acquisitions, higher legal
and litigation expenses associated with our anti-counterfeiting initiative, and variable costs associated with increased sales at VaporBeast partially offset by a receivable reserve reversal and prepayment penalty, both of which are associated
with the loan issued to a supplier in the second quarter of 2018 which was repaid during the third quarter of 2018.
Interest Expense: For the nine months ended
September 30, 2018, interest expense decreased to $11.1 million from $13.0 million for the nine months ended September 30, 2017, as a result of lower interest rates from our March 2018 refinancing of our credit facility.
Interest Income: For the nine months ended
September 30, 2018, interest income increased to $0.3 million from less than $0.1 million for the nine months ended September 30, 2017, as a result of interest and fees received from a note receivable issued to a supplier during the second
quarter of 2018.
Income Tax Expense: Our income tax expense
of $4.2 million was 17.0% of income before income taxes for the nine months ended September 30, 2018, compared to 19.3% for the nine months ended September 30, 2017. The decrease is a result of the change in the federal tax rate from 35% to 21%,
the change in the Kentucky tax rate from 6% to 5%, and lower stock option exercises in 2018 compared to 2017.
Investment Income: Investment income
relating to investment of the MSA escrow deposits was approximately $0.3 million for the nine months ended September 30, 2018 and 2017.
Loss on Extinguishment of Debt: For the nine months ended September 30, 2018, loss on extinguishment of debt was $2.4 million as the result of refinancing our credit facility in the first quarter of
2018. For the nine months ended September 30, 2017, loss on extinguishment of debt was $6.1 million as the result of refinancing our credit facility in the first quarter of 2017.
Consolidated Net Income: Due to the factors
described above, consolidated net income for the nine months ended September 30, 2018 and 2017, was $20.3 million and $16.1 million, respectively.
Net Loss Attributable to Non-Controlling Interest:
Net loss attributable to non-controlling interest of $0.6 million for the nine months ended September 30, 2017, is related to Vapor Shark being a VIE in the second quarter of 2017.
Net Income Attributable to Turning Point Brands,
Inc.: Due to the factors described above, net income attributable to Turning Point Brands, Inc., for the nine months ended September 30, 2018 and 2017, was $20.3 million and $16.7 million, respectively.
EBITDA and Adjusted EBITDA
To supplement our financial information presented in accordance with generally accepted accounting principles in the United States, or U.S. GAAP, we use
non-U.S. GAAP financial measures including EBITDA and Adjusted EBITDA. We believe Adjusted EBITDA provides useful information to management and investors regarding certain financial and business trends relating to our financial condition and
results of operations. Adjusted EBITDA is used by management to compare our performance to that of prior periods for trend analyses and planning purposes and is presented to our Board of Directors. We believe that EBITDA and Adjusted EBITDA are
appropriate measures of operating performance because they eliminate the impact of expenses that do not relate to operating performance. In addition, our credit agreements contain financial covenants which use Adjusted EBITDA calculations.
We define “EBITDA” as net income before interest expense, loss on extinguishment of debt, provision for income taxes, depreciation, and amortization. We
define “Adjusted EBITDA” as net income before interest expense, loss on extinguishment of debt, provision for income taxes, depreciation, amortization, other non-cash items, and other items we do not consider ordinary course in our evaluation of
ongoing operating performance.
Non-U.S. GAAP measures should not be considered a substitute for, or superior to, financial measures calculated in accordance with U.S. GAAP. Adjusted
EBITDA excludes significant expenses required to be recorded in our financial statements by U.S. GAAP and is subject to inherent limitations. Other companies in our industry may calculate this non-U.S. GAAP measure differently than we do or may
not calculate it at all, limiting its usefulness as a comparative measure. The tables below provide reconciliations between net income and Adjusted EBITDA.
(in thousands)
|
Three Months Ended
September 30,
|
|||||||
2018
|
2017
|
|||||||
Consolidated net income
|
$
|
7,954
|
$
|
7,374
|
||||
Add:
|
||||||||
Interest expense
|
3,836
|
4,027
|
||||||
Interest income
|
(134
|
)
|
(4
|
)
|
||||
Income tax expense
|
1,436
|
3,110
|
||||||
Depreciation expense
|
479
|
421
|
||||||
Amortization expense
|
206
|
175
|
||||||
EBITDA
|
$
|
13,777
|
$
|
15,103
|
||||
Components of Adjusted EBITDA
|
||||||||
LIFO adjustment (a)
|
201
|
(641
|
)
|
|||||
Pension/postretirement expense (b)
|
(18
|
)
|
84
|
|||||
Stock options, restricted stock, and incentives expense (c)
|
367
|
226
|
||||||
Foreign exchange hedging (d)
|
70
|
-
|
||||||
Strategic initiatives (e)
|
1,126
|
219
|
||||||
New product launch costs (f)
|
545
|
566
|
||||||
Product line rationalizations (g)
|
301
|
314
|
||||||
Organizational development (h)
|
98
|
-
|
||||||
Adjusted EBITDA
|
$
|
16,467
|
$
|
15,871
|
(a) |
Represents expense related to an inventory valuation allowance for last-in, first-out (“LIFO”) reporting.
|
(b) |
Represents our non-cash Pension/postretirement expense.
|
(c) |
Represents non-cash stock options, restricted stock and incentives expense.
|
(d) |
Represents non-cash gain and loss stemming from our foreign exchange hedging activities.
|
(e) |
Represents the fees incurred for the study of strategic initiatives and acquisition expenses.
|
(f) |
Represents product launch costs of our new product lines.
|
(g) |
Represents costs associated with discontinued products related to product line rationalization.
|
(h) |
Represents costs associated with departmental restructuring.
|
(in thousands)
|
Nine Months Ended
September 30,
|
|||||||
2018
|
2017
|
|||||||
Net income attributable to Turning Point Brands, Inc.
|
$
|
20,305
|
$
|
16,690
|
||||
Add:
|
||||||||
Interest expense
|
11,073
|
13,010
|
||||||
Interest income
|
(262
|
)
|
(8
|
)
|
||||
Loss on extinguishment of debt
|
2,384
|
6,116
|
||||||
Income tax expense
|
4,153
|
3,850
|
||||||
Depreciation expense
|
1,596
|
1,192
|
||||||
Amortization expense
|
557
|
526
|
||||||
EBITDA
|
$
|
39,806
|
$
|
41,376
|
||||
Components of Adjusted EBITDA
|
||||||||
LIFO adjustment (a)
|
144
|
246
|
||||||
Pension/postretirement expense (b)
|
254
|
252
|
||||||
Stock options, restricted stock, and incentives expense (c)
|
1,056
|
446
|
||||||
Foreign exchange hedging (d)
|
70
|
(90
|
)
|
|||||
Product line rationalizations (e)
|
1,309
|
314
|
||||||
Strategic initiatives (f)
|
2,755
|
990
|
||||||
New product launch costs (g)
|
1,227
|
1,727
|
||||||
Organizational development (h)
|
778
|
-
|
||||||
Adjusted EBITDA
|
$
|
47,399
|
$
|
45,261
|
(a) |
Represents expense related to an inventory valuation allowance for last-in, first-out (“LIFO”) reporting.
|
(b) |
Represents our non-cash Pension/postretirement expense.
|
(c) |
Represents non-cash stock options, restricted stock and incentives expense.
|
(d) |
Represents non-cash gain and loss stemming from our foreign exchange hedging activities.
|
(e) |
Represents costs associated with discontinued products related to product line rationalization.
|
(f) |
Represents the fees incurred for the study of strategic initiatives and acquisition expenses.
|
(g) |
Represents product launch costs of our new product lines.
|
(h) |
Represents costs associated with departmental restructuring.
|
Liquidity and Capital Reserves
Our principal uses for cash are working capital, debt service, and capital expenditures. We believe our cash flows from operations and borrowing
availability under our 2018 Revolving Credit Facility (as defined herein) are adequate to satisfy our operating cash requirements for the foreseeable future.
Our working capital, which we define as current assets less current liabilities, increased $6.8 million to $48.1 million at September 30, 2018, compared
with $41.3 million at December 31, 2017. The increase in working capital is primarily due to inventory increases resulting from the Vapor Supply asset purchase and the IVG acquisition, in addition to pre-tariff inventory buys within our existing
operations, partially offset by borrowings against the 2018 Revolving Credit Facility to support acquisitions.
As of
|
||||||||
(in thousands)
|
September 30,
2018
|
December 31,
2017
|
||||||
Current assets
|
$
|
112,223
|
$
|
79,493
|
||||
Current liabilities
|
64,161
|
38,230
|
||||||
Working capital
|
$
|
48,062
|
$
|
41,263
|
Cash Flows from Operating Activities
For the nine months
ended September 30, 2018, net cash provided by operating activities was $1.0 million compared to net cash provided by operating activities of $20.4 million for the nine months
ended September 30, 2017, a decrease of $19.4 million, primarily due to inventory increases to support increased sales and pre-tariff inventory buys.
Cash Flows from Investing Activities
For the nine months
ended September 30, 2018, net cash used by investing activities was $21.9 million compared to net cash used in investing activities of $0.5 million for the nine months
ended September 30, 2017, a decrease of $21.5 million, primarily due to the Vapor Supply and IVG acquisitions.
Cash Flows from Financing Activities
For the nine months
ended September 30, 2018, net cash provided by financing activities was $16.7 million compared to net cash used in financing activities of $18.2 million for the nine months
ended September 30, 2017, an increase of $34.9 million, primarily due to borrowings against our 2018 Revolving Credit Facility to fund our investing activities.
Dividends
On November 9, 2017, our Board of Directors approved the initiation of a cash dividend to shareholders. The initial quarterly dividend of $0.04 per
common share was paid on December 15, 2017, to shareholders of record at the close of business on November 27, 2017. The most recent dividend of $0.04 per common share was paid on October 12, 2018, to shareholders of record at the close of
business on September 24, 2018.
Long-Term Debt
As of September 30, 2018, we were in compliance with the financial and restrictive covenants of the 2018 Credit Facility. The following table provides
outstanding balances of our debt instruments.
(in thousands)
|
September 30,
2018
|
December 31,
2017
|
||||||
2018 Revolving Credit Facility
|
$
|
30,000
|
$
|
-
|
||||
2018 First Lien Term Loan
|
156,000
|
-
|
||||||
2018 Second Lien Term Loan
|
40,000
|
-
|
||||||
Note payable - IVG
|
4,000
|
-
|
||||||
2017 Revolving Credit Facility
|
-
|
8,000
|
||||||
2017 First Lien First Out Term Loan
|
-
|
105,875
|
||||||
2017 First Lien Second Out Term Loan
|
-
|
34,738
|
||||||
2017 Second Lien Term Loan
|
-
|
55,000
|
||||||
Note payable - VaporBeast
|
-
|
2,000
|
||||||
230,000
|
205,613
|
|||||||
Less deferred financing charges
|
(3,471
|
)
|
(3,573
|
)
|
||||
Less revolving credit facility
|
(30,000
|
)
|
(8,000
|
)
|
||||
Less current maturities of long-term debt
|
(8,000
|
)
|
(7,850
|
)
|
||||
Notes payable and long-term debt
|
$
|
188,529
|
$
|
186,190
|
2018 Credit Facility
The 2018 Credit Facility contains customary events of default including payment defaults, breaches of representations and warranties, covenant defaults,
cross-defaults to certain other material indebtedness in excess of specified amounts, certain events of bankruptcy and insolvency, certain ERISA events, judgments in excess of specified amounts, and change in control defaults. The 2018 Credit
Facility also contains certain negative covenants customary for facilities of these types including covenants that, subject to exceptions described in the 2018 Credit Facility, restrict our ability: (i) to pledge assets, (ii) to incur additional
indebtedness, (iii) to pay dividends, (iv) to make distributions, (v) to sell assets, and (vi) to make investments. Refer to Note 17 of Notes to Consolidated Financial Statements for further information regarding dividend restrictions.
2018 First Lien Credit Facility: The 2018
First Lien Term Loan and the 2018 Revolving Credit Facility bear interest at LIBOR plus a spread of 2.75% to 3.50% based on our senior leverage ratio. The 2018 First Lien Term Loan has quarterly required payments of $2.0 million beginning June
30, 2018, increasing to $3.0 million on June 30, 2020, and increasing to $4.0 million on June 30, 2022. The 2018 First Lien Credit Facility has a maturity date of March 7, 2023. The 2018 First Lien Term Loan is secured by a first priority lien on
substantially all of the assets of the borrowers and the guarantors thereunder, including a pledge of our capital stock, other than certain excluded assets (the “Collateral”). The 2018 First Lien Credit Facility contains certain financial
covenants including maximum senior leverage ratio of 3.50x with step-downs to 3.00x, a maximum total leverage ratio of 4.50x with step-downs to 4.00x, and a minimum fixed charge coverage ratio of 1.20x. The weighted average interest rate of the
2018 First Lien Term Loan was 5.34% at September 30, 2018. The weighted average interest rate of the 2018 Revolving Credit Facility was 6.05% at September 30, 2018. At September 30, 2018, we had $30.0 million of borrowings outstanding under the 2018 Revolving Credit
Facility. The $20.0 million unused portion of the 2018 Revolving Credit Facility is reduced by a $0.5 million letter of credit with Fifth Third Bank, resulting in $19.5 million of availability under the 2018 Revolving Credit Facility at September 30, 2018.
2018 Second Lien Credit Facility: The 2018
Second Lien Credit Facility bears interest at a rate of LIBOR plus 7.00% and has a maturity date of March 7, 2024. The 2018 Second Lien Term Loan is secured by a second priority interest in the Collateral and is guaranteed by the same entities as
the 2018 First Lien Term Loan. The 2018 Second Lien Credit Facility contains certain financial covenants including a maximum senior leverage ratio of 3.75x with step-downs to 3.50x, a maximum total leverage ratio of 4.75x with step-downs to
4.50x, and a minimum fixed charge coverage ratio of 1.10x. The weighted average interest rate of the 2018 Second Lien Term Loan was 9.05% at September 30, 2018.
Note Payable – IVG
In September 2018, we issued a note payable to IVG’s former shareholders (“IVG Note”). The IVG Note is $4.0 million principal with 6.0%
interest compounding annually and matures on March 1, 2020.
Note Payable – VaporBeast
On November 30, 2016, we issued a note payable to VaporBeast’s former shareholders (“VaporBeast Note”). The VaporBeast Note was $2.0 million principal
with 6% interest compounded monthly and matured on May 30, 2018, at which time it was paid in full.
Off-balance Sheet Arrangements
During the third quarter of 2018 we executed forward contracts for the purchase of €2.3 million. During 2017, we executed no forward contracts. At
September 30, 2018, and December 31, 2017, we had forward contracts for the purchase of €5.5 million and €0 million, respectively.
Contractual Obligations
As of September 30, 2018, there had been no material changes outside the ordinary course of business to our contractual obligations as of December 31,
2017, as reported in our 2017 Annual Report on Form 10-K, with the exception of changes to our long-term debt obligations due to the refinancing discussed in the ‘Long-Term Debt’ section.
The following tables summarize our contractual obligations (in thousands):
Payments due by period as of September 30, 2018
|
||||||||||||||||||||
Total
|
Less than 1
year
|
1-3 years
|
4-5 years
|
More than 5
years
|
||||||||||||||||
Long-term debt obligations, including interest
|
$
|
280,795
|
$
|
51,969
|
$
|
44,632
|
$
|
142,600
|
$
|
41,594
|
Payments due by period as of December 31, 2017
|
||||||||||||||||||||
Total
|
Less than 1
year
|
1-3 years
|
4-5 years
|
More than 5
years
|
||||||||||||||||
Long-term debt obligations, including interest
|
$
|
266,052
|
$
|
29,803
|
$
|
42,444
|
$
|
193,805
|
$
|
-
|
Inflation
We believe that any effect of inflation at current levels will be minimal. Historically, we have been able to increase prices at a rate equal to or
greater than that of inflation and believe that we will continue to be able to do so for the foreseeable future. In addition, we have been able to maintain a relatively stable variable cost structure for our products due, in part, to our
successful procurement with regard to our tobacco products and, in part, to our existing contractual agreement for the purchase of our premium cigarette papers.
Foreign Currency Sensitivity
Although we engaged in hedging inventory purchases during the three months ended September 30, 2018, there have been no material changes in our exposure
to exchange rate fluctuation risk, as reported within our 2017 Annual Report on Form 10-K, during the period. Please refer to our ‘Quantitative and Qualitative Disclosures about Market Risk’ included in our 2017 Annual Report on Form 10-K filed
with the SEC.
Credit Risk
There have been no material changes in our exposure to credit risk, as reported within our 2017 Annual Report on Form 10-K, during the three months ended
September 30, 2018. Please refer to our ‘Quantitative and Qualitative Disclosures about Market Risk’ included in our 2017 Annual Report on Form 10-K filed with the SEC.
Interest Rate Sensitivity
Our March 2018 refinancing resulted in all of our long-term debt instruments having variable interest rates that fluctuate with market rates. To reduce
the volatility of future cash flows, we entered into interest rate swap agreements with lenders under the 2018 Credit Facility in March 2018. At September 30, 2018, $70 million of our outstanding long-term debt carrying variable rates is covered
by the interest rate swap agreements and, thus, effectively bears interest at a fixed rate. We believe the effect, if any, of reasonably possible near-term changes in interest rates on our consolidated financial position, results of operations,
or cash flows would not be significant. A 1% increase in the interest rate would change pre-tax income by approximately $1.5 million per year. Refer to Note 4 of Notes to Consolidated Financial Statements located at Part I, Item 1, for additional
information regarding the interest rate swaps.
We have carried out an evaluation under the supervision, and with the participation of, our management including our Chief Executive Officer (“CEO”),
Chief Financial Officer (“CFO”), and Chief Accounting Officer (“CAO”), of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act of 1934, as
amended (the “Act”)) as of September 30, 2018. Based upon the evaluation, our CEO, CFO, and CAO concluded our disclosure controls and procedures are effective to provide
reasonable assurance that information required to be disclosed by us in the reports we file or submit under the Act is: (i) recorded, processed, summarized, and reported within the time periods specified in the Securities and Exchange
Commission’s rules and forms and (ii) accumulated and communicated to our management, including our principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding
required disclosures.
There have been no changes in the Company’s internal control over financial reporting during the most recent fiscal quarter which have
materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.
PART II—OTHER INFORMATION
We are a party from time to time to various proceedings in the ordinary course of business. For a description of the Master Settlement Agreement, to
which we are a party, see “Financial Statements and Supplementary Data - Note 2 Summary of Significant Accounting Policies: Risk and Uncertainties.” Other than the proceedings mentioned below, there is no material litigation, arbitration or
governmental proceeding currently pending against us or any of our officers or directors in their capacity as such, and we and our officers and directors have not been subject to any such proceeding.
Other major tobacco companies are defendants in product liability claims. In a number of these cases, the amounts of punitive and compensatory damages
sought are significant and could have a material adverse effect on our business and results of operations. The Company is a defendant in certain cases which have been dormant for many years, which cases have now been dismissed with prejudice.
We are subject to several lawsuits alleging personal injuries resulting from malfunctioning vaporizer devices and may be subject to claims in the future
relating to our other NewGen products. We are still evaluating these claims and the potential defenses to them. For example, we did not design or manufacture the products at issue; rather, we were merely the distributor. Nonetheless, there can
be no assurance that we will prevail in these cases, and they could have a material adverse effect on our business and results of operations. Because of their relative novelty, electronic cigarette and vaporizer product manufacturers and sellers
have only recently become subject to litigation.
See ‘Risk Factors—We may become subject to significant product liability litigation’ within our 2017 Annual Report on Form 10-K for additional details.
In addition to the other information set forth in this report, carefully consider the factors discussed in the ‘Risk Factors’ section contained in our
2017 Annual Report on Form 10-K. There have been no material changes to the Risk Factors set forth in the 2017 Annual Report on Form 10-K.
During the period of this report, the Company issued 153,079 unregistered shares of the Company’s common stock to the former stockholders of IVG as partial
consideration for the Company’s acquisition of IVG. In September 2018, the Company acquired IVG for total consideration of $23.7 million satisfied through $14.4 million paid in cash, 153,079 shares of common stock with a fair value of $5.3
million, and a $4.0 million note payable to IVG’s former owners. Refer to Note 3 of Notes to Consolidated Financial Statements located at Part I, Item 1, for additional information.
The issuance of unregistered shares was made by the Company in reliance upon Section 4(a)(2) of the Securities Act of 1933, a amended (the “1933 Act”)
and Regulation D promulgated thereunder. All of the individuals and/or entities that received the unregistered securities were “accredited investors” and were all known to the Company and its management through pre-existing business
relationships. All purchasers were provided access to all material information, which they requested, and all information necessary to verify such information and were afforded access to management of the Company in connection with their
purchases. All purchasers of the unregistered securities acquired such securities for investment and not with a view toward distribution, acknowledging such intent to the Company. All certificates representing such securities that were issued
contained restrictive legends, prohibiting further transfer of the securities, without such securities either being first registered or otherwise exempt from registration in any further resale or disposition.
Not applicable.
Not applicable.
None.
Exhibit No.
|
Description
|
International Vapor Group Stock Purchase Agreement dated as of September 5, 2018, between Turning Point Brands, Inc. and International
Vapor Group, LLC.*+
|
|
Rule 13a-14(a)/15d-14(a) Certification of Lawrence S. Wexler.*
|
|
Rule 13a-14(a)/15d-14(a) Certification of Robert Lavan.*
|
|
Rule 13a-14(a)/15d-14(a) Certification of Brian Wigginton.*
|
|
Section 1350 Certifications pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.*
|
|
101
|
XBRL (eXtensible Business Reporting Language). The following materials from Turning Point Brands, Inc.’s Quarterly Report on Form 10-Q for the quarter
ended September 30, 2018, filed on November 7, 2018, formatted in XBRL: (i) consolidated balance sheets, (ii) consolidated statements of income, (iii) consolidated statements of comprehensive income, (iv) consolidated statements of cash
flows, and (v) the notes to consolidated financial statements.*
|
* |
Filed or furnished herewith
|
+ |
Certain schedules, appendices and exhibits to this agreement have been omitted in accordance with Item 601(b)(2) of Regulation S-K.
A copy of any omitted schedule and/or exhibit will be furnished supplementally to the Securities and Exchange Commission staff upon request.
|
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned thereunto duly authorized.
TURNING POINT BRANDS, INC.
|
||
By: /s/ Lawrence S. Wexler
|
||
Name: Lawrence S. Wexler
|
||
Title: President and Chief Executive Officer
|
||
By: /s/ Robert Lavan
|
||
Name: Robert Lavan
|
||
Title: Chief Financial Officer
|
||
By: /s/ Brian Wigginton
|
||
Name: Brian Wigginton
|
||
Title: Chief Accounting Officer
|
Date: November 7, 2018
46